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ABSTRACT
BRENNA M DOHENY. Estrogen signaling and endocrine disruption potential in the
embryonic development of the female reproductive tract of the American alligator,
Alligator mississippiensis. (Under the direction of LOUIS J. GUILLETTE, JR. and
SHERINE S.L. CHAN).

Perturbation of endocrine signaling during critical embryonic developmental
windows has been implicated in many female reproductive system disorders.
Reproductive tract anomalies in women exposed in utero to synthetic estrogen
diethylstilbestrol, prescribed as a miscarriage preventative, provided some of the first
evidence for this “embryonic origins of adult disease” paradigm and suggested a role for
estrogen signaling in female reproductive tract (FRT) differentiation.
Developmental studies of FRT in other vertebrates have great value in furthering
our understanding of embryonic origins of reproductive disorders. The alligator is a
particularly intriguing model as an environmental sentinel species with temperature
dependent sex determination, which allows for controlled manipulation of sexual
differentiation in laboratory experiments. The signals involved in determining regionally
specific cell fates in FRT of alligators and other crocodilians are not yet known, but
multiple studies in their closest extant evolutionary relative, birds, underscore the role of
estrogen signaling in this process.
Here I seek to characterize the role of estrogen signaling in the developing
alligator FRT. I treated alligator embryos with estradiol-17β (E2) and pharmaceutical
agonists that are selective for their two estrogen receptor isoforms, ERα and ERβ.
The ERα agonist, propyl pyrazole triol (PPT), induced significant enlargement of the
developing FRT, compared with controls and E2 and ERβ agonist treatments. Histological
analysis revealed precocious glandulogenesis and connective tissue differentiation
similar to mature FRT in these enlarged tissues. PPT treatment also altered expression of
steroid hormone receptors and growth factor IGF1. Further experiments assessing this
xiii

CHAPTER 1:
General Introduction

1.1. Question formulation
At the heart of this dissertation is my underlying interest in the field of
environmental endocrine disruption, which synergizes reproductive and developmental
biology and endocrinology and has direct, far-reaching impacts on environmental
health. The concept of environmental endocrine disruption arose when a growing
scientific literature on reproductive impairments in both humans and wildlife led a
trans-disciplinary group of experts to come together at a meeting in 1991 known as the
Wingspread Work Session. Their consensus statement laid out the founding principles:
that developmental exposure to hormonally active agents could disrupt normal
developmental patterning at structural and functional levels that lead to disorders of the
adult reproductive system (Colborn et al., 1992; Colborn et al., 1996).
The major human health evidence for this “developmental origins of adult
disease” paradigm came in large part from the unanticipated adverse effects of a synthetic
estrogen, diethylstilbestrol (DES), used as a miscarriage preventative from 1947-1971
(United States Centers for Disease Control and Prevention, 2011). This usage ceased
when it was found that young women who were exposed in utero to DES developed
an otherwise extremely rare cancer only found in much older women, vaginal clear
cell adenocarcinoma (Herbst et al., 1971). Other structural disorders of the female
reproductive tract (FRT) have been found in these “DES daughters,” such as T-shaped
uterus and vaginal adenosis, and these women face great difficulties in achieving and
maintaining successful pregnancies (reviewed in Bern, 1992; Crain et al., 2008; Newbold,
2004).
DES exposure-induced FRT disorders are rooted in disruption of the normal
differentiation of the embryonic Müllerian duct (MD) into specialized FRT regional
1

structures, the Fallopian tubes, uterus and upper vagina. Laboratory studies in mice
have recapitulated the FRT disorders seen in human DES daughters, and have provided
insight into the mechanisms underlying FRT disruptions due to embryonic DES exposure
(reviewed in Newbold, 2004).
While laboratory models are essential for understanding the mechanisms
underlying environmental endocrine disruption, wildlife models, exposed to real-world
levels of environmental endocrine disrupting contaminants (EDCs) through various
routes and in various mixtures, are equally critical for understanding potential health
impacts. It was while reviewing studies on the effects of contaminants on wildlife in the
Great Lakes region that Theo Colborn formulated the ideas that birthed the endocrine
disruption hypothesis and led her to organize the Wingspread Work Session (Colborn et
al., 1996).
The American alligator emerged as a particularly valuable wildlife model due
to a discovery not unlike the story of DES exposure in humans. A severe population
decline in alligators living in Lake Apopka, FL, following a major spill of the pesticide
dichlorodiphenyltrichloroethane (DDT) in 1980, led to the recruitment of Louis J.
Guillette, Jr., by the Florida Fish and Wildlife Conservation Commission (then Florida
Game and Freshwater Fish Commission) to investigate this anomalous population, as
well as overarching questions of alligator reproductive biology.
By comparing alligators in Lake Apopka with alligator populations in more
pristine Florida lakes, Dr. Guillette’s research group and collaborators established that
Apopka alligators had higher serum, tissue and egg yolk levels of many contaminants,
most notably DDT metabolite p,p’-dichlorodiphenyldichloroethylene (DDE) (reviewed
in Woodward et al., 2011). Experiments involving field collection of eggs and controlled
incubation in the laboratory showed that Apopka alligators developed altered gonadal and
external genitalia morphology compared with alligators from a reference site (reviewed
in Guillette et al., 2000; Guillette and Moore, 2006; Milnes and Guillette, 2008). These
2

results strongly suggested that developmental exposure to EDCs, transferred from mother
to embryo via yolk, were the basis for the adverse outcomes seen in Apopka alligators:
the decreased viability and hatching success of eggs as well as the reproductive system
anomalies (Hamlin and Guillette, 2011).
This long-term case study coupled with the unique attributes of alligators have led
to more than three decades of research in our laboratory utilizing the American alligator
as a sentinel for studying environmental influences on reproductive health. Alligators are
long-lived, and have a very high site affinity, which offers the opportunity to correlate
reproductive health anomalies with contaminant exposure. Their semi-aquatic lifestyle
and position as top predators also make alligators particularly susceptible to exposure
to EDCs, many of which biomagnify across trophic levels and bioaccumulate in tissues
(Milnes and Guillette, 2008). What really sets alligators apart as a model species,
however, is that sex determination in the alligator is temperature dependent, rather than
genetic (Ferguson and Joanen, 1982; Ferguson, 1985). Incubation of alligator eggs at
30°C during a critical window known as the thermosensitive period (TSP) produces
all females, while incubation at 33°C during the TSP produces all males (Ferguson and
Joanen, 1982; Lang and Andrews, 1994). This makes the alligator an ideal experimental
model for research involving sexual differentiation, and the effects of environmental
factors such as EDCs on this process, as the sex of developing embryos can be controlled
and manipulated in the lab via incubation temperature.
In efforts to better understand alligator reproductive health, adult alligator FRT
structure and function and adult reproductive endocrine physiology have been studied
by our research group. The development of the alligator FRT has been a neglected area
of inquiry, however. Considering the significance of FRT development in the field of
endocrine disruption research thanks to the pivotal role the DES story played in its
formulation, the underlying question for my dissertation research arose quite organically:
Is the developing female reproductive tract of the American alligator a potential target
for endocrine disruption?
3

1.2. Background
1.2.1. Female reproductive tract development in mammals
In the mammalian system, with XX/XY chromosomal genetic sex determination,
the FRT pathway has long been considered to be the “default” state. During early
development, the embryo develops a bipotential gonad and both male (Wolffian duct) and
female (Müllerian duct, MD) reproductive tract primordia. The transcription factor Sry
on the male Y chromosome is necessary to induce differentiation of the early bipotential
gonad to testis, which produces anti-Müllerian hormone (AMH) and testosterone to
induce MD degeneration and Wolffian duct (WD) promotion. In the absence of these
male-promoting factors, the MD differentiates into the FRT, which encompasses the
fallopian tubes, uterus, cervix and upper vagina. (reviewed in Gilbert, 2000; Kobayashi
and Behringer, 2003; vom Saal et al., 1992; Yin and Ma, 2005)
Despite this “default” nature of mammalian FRT development, studies have
shown that there are many important genetic factors involved in promoting regional
differentiation of the MD (reviewed in Kobayashi and Behringer, 2003). Of interest when
considering the potential role of estrogen signaling in FRT development is the regional
expression of Homeobox (Hox) genes, the master regulators of axial patterning during
embryogenesis. The chromosomal position of these genes from 3’ to 5’ corresponds
with their anteroposterior expression along the body axis of the developing embryo
(Krumlauf, 1994). In the developing mammalian FRT, regional expression of the Hoxa
5’ genes correlates directly with regional differentiation. Hoxa9 is expressed in the
developing oviduct, Hoxa10 in the uterus, Hoxa11 in the cervix and Hoxa13 in the upper
vagina (Taylor et al., 1997). This regional expression of Hox genes is also present in
the adult FRT and related to fertility and implantation success. Targeted disruption of
either Hoxa10 (Satokata et al., 1995) or Hoxa11 (Hsieh-Li et al., 1995) results in female
infertility. Experimental evidence suggests estrogen signaling is involved in regulation of
4

regional expression of Hoxa 5’ genes in the developing FRT. Developmental exposure to
DES in mice results in a posterior shift of Hoxa9, Hoxa10 and Hoxa11 gene expression,
accompanied by reproductive tract abnormalities indicative of a posterior shift of
specialized FRT structures (Block et al., 2000; Ma et al., 1998).
Whether estrogen signaling plays a role in normal mammalian FRT development
is uncertain. Estrogens have been shown to protect the MD from degeneration induced
by testosterone and AMH (reviewed in vom Saal et al., 1992). In estrogen receptor
knockout mouse models, the MD differentiates into the normal FRT regional structures,
but the uterus is much smaller in size and unresponsive to estrogen (reviewed in Emmen
and Korach, 2003). It is hypothesized that the mammalian MD undergoes an estrogenindependent “organogenetic” differentiation in early development that determines
regional structures, and an estrogen driven “functional” differentiation at reproductive
maturity during estrous cycles to allow for pregnancy (Kurita, 2011).

1.2.2. Female reproductive tract development in birds
Avian sex determination is chromosomal, with a ZZ/ZW system, but in contrast
to mammals, the female is the heterogametic sex. The actual genetic factors involved in
gonadal sex differentiation in birds were unknown until quite recently. A Z-linked gene,
DMRT1, is involved in testis determination in a dosage-dependent fashion, in that two
copies, found in ZZ males, are necessary (Smith et al., 2009). In a ZW female, the left
gonad differentiates into an ovary, which produces estrogens that counter the effects
of AMH, leading to oviduct development (Hamilton, 1961; reviewed in Hermansson,
2007). In most bird species, aside from the brown kiwi and some falconiformes, only the
left ovary and oviduct develop (Johnson, 1986). Both male and female gonads produce
AMH, but only the left gonad in females produces estrogen to counter its effects, and
the left MD has a higher abundance of estrogen receptors. This protects the left MD
and promotes oviductal growth and differentiation, while the right gonad atrophies and
5

the right MD degenerates (Hutson et al., 1985; Hutson et al., 1983; MacLaughlin et al.,
1983). It is thought that this asymmetrical female reproductive system evolved as one of
many adaptations that make birds capable of flight (Witschi, 1935).
Estrogen appears to be a necessary factor in normal avian FRT differentiation.
Female embryos have higher plasma estradiol than males (Woods and Brazzill, 1981),
and administration of estrogen to male embryos results in MD retention (Willier et
al., 1937). In ovo treatment with an aromatase inhibitor while the gonads are in a
bipotential state results in sex reversal of genetically female chickens, with full testicular
development and absence of both oviducts (Elbrecht and Smith, 1992).
The developing avian FRT is particularly sensitive to exogenous estrogenic input,
and in fact there is a long history of research utilizing the developing avian oviduct as
a test system for studying estrogen action (reviewed in Dougherty and Sanders, 2005).
Studies in the 1930s and 1940s documented left oviductal hypertrophy and retention of
the right oviduct when immature chickens were dosed with exogenous estrogens (Munro
and Kosin, 1943). Further studies have shown that in ovo estrogenic stimulation induces
cytodifferentiation and glandular morphogenesis in the avian oviduct (Andrews and Teng,
1979; Berg et al., 2001; Kohler et al., 1969; Oka and Schimke, 1969b).
Similarly to the DES story in humans, wild birds have suffered unintended FRT
disruption thanks to the widespread use of the insecticide DDT for mosquito control from
the time of WWII until its ban in 1972. Exposure to DDT and its persistent metabolite
p,p’-DDE was directly correlated with eggshell thinning and other reproductive
anomalies, which led to serious declines in exposed populations (reviewed in Cooke,
1973). Adult exposure to DDT was thought to result in impaired shell formation in
the oviduct via inhibition of carbonic anhydrase (Bitman et al., 1969), but more recent
studies have supported the endocrine disruption paradigm of developmental exposure
leading to adult disorders. In ovo exposure to DDT resulted in reproductive dysfunctions
in adult chickens, including production of eggs with significantly thinner, or even absent,
6

shells (Hermansson, 2007; Holm et al., 2006). Studies in Japanese quail have also
shown disruptions of important oviductal structures and reduced expression of calcium
regulating factors due to in ovo exposure to DDT (Kamata et al., 2009).

1.2.3. The alligator female reproductive tract
The adult alligator FRT is a highly regionalized tissue, in which seven
morphologically and functionally distinct regions have been described: the anterior
infundibulum, posterior infundibulum, tube, uterotubular junction, anterior uterus,
posterior uterus, and vagina (Fig. 1.1). As members of the Archosaurian evolutionary
lineage, encompassing birds, crocodilians and extinct dinosaurs, female alligators have
a reproductive tract that shares more similarities with birds than other reptiles (Palmer
and Guillette, 1992). In non-Archosaurian amniotes, the uterine region produces both the
fibrous proteins that form the eggshell membrane and the outer calcareous layer of the
eggshell, in a sequential process (Palmer, 1990). In Archosaurs, there are two spatially
distinct regions, complete with distinct glandular structures that produce these different
secretory products, identified here in the alligator as the anterior and posterior uterus,
but also referred to as the “fiber region” and “calcium region” (Palmer, 1990; Palmer
and Guillette, 1992). Thus Archosaurian eggs can be packaged in an “assembly line”
fashion, an evolutionary adaptation that has been seen as an innovation allowing for flight
in birds (Guillette, 1991). The major differences between crocodilians and their winged
counterparts are that crocodilians retain paired reproductive structures, and process
an entire clutch of eggs through their oviducts at once, while birds only retain the left
reproductive organs and process their eggs through their oviducts one at a time (Palmer,
1990).
As described by Palmer and Guillette (1991), three regions of the alligator FRT
are of particular functional importance: the tube, the anterior uterus and the posterior
uterus. On a structural and functional level, the tubal region has a tall columnar
7

epithelium of ciliated and microvillous secretory cells and an extensive network
of branched acinar glands that secrete glycosaminoglycans. The tube is the most
biosynthetically active region of the reproductively active alligator FRT, and it produces
albumen and ovotransferrin proteins (Buhi et al., 1999). The anterior uterus secretes
protein fibers that form the eggshell membranes (Buhi et al., 1999) from branched tubular
glands with numerous visible eosinophilic secretory granules. The posterior uterus is the
site of the shell gland, involved in producing eggshells, and the branched tubular glands
have fewer secretory granules than the anterior uterus, and the luminal epithelium is
lower (Palmer and Guillette, 1992).
When reproductively active, the alligator FRT undergoes dramatic changes in
size. A non-reproductive female two meters in total body length reportedly has oviducts
of 45 cm in length, which can grow to be 1.5-2.5 m in length under stimulation by
endogenous estrogen during the reproductive cycle (Guillette et al., 1997). This spike in
estrogen signaling also induces extensive glandular development to enable the FRT to
produce all of the secretory products necessary for proper egg packaging (Palmer, 1990).

1.2.4. Estrogens and alligator female reproductive tract development
Considering the response of the adult alligator FRT to estrogen during
reproductive cyclicity, and the shared Archosaurian lineage between birds and alligators,
it is probable that estrogens play a role in the developing FRT of the alligator similar to
that in the developing avian FRT. Early studies on alligator FRT development support this
hypothesis. In the 1930s, Thomas Forbes studied the role of steroid hormones in alligator
reproductive system development by treating 15-month-old juvenile female alligators
with large daily injections of estradiol benzoate (EB) over an 80 day period, resulting
in massive oviductal hypertrophy (Forbes, 1938a; Forbes, 1938b). Over 50 years later,
in studies on alligator MD regression, Austin (1989) noted that neonatal exposure to
estrogen via implanted pellets also induced oviductal hypertrophy.
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Experimental treatment with hormones in ovo has also been shown to
influence alligator FRT development. In their in-depth investigation on the TSP of sex
determination in alligators, Lang and Andrews (1994) showed that dosing embryonic
alligators with estradiol-17β (E2) prior to incubation at the male producing temperature
(MPT) during the TSP resulted in 100% gonadal sex reversal (i.e. development of ovaries
rather than testes), and “some” oviductal hypertrophy relative to untreated animals
incubated at the female producing temperature (FPT). Hypertrophied MDs were also
reported following in ovo treatment with norethindrone, an aromatase inhibitor and
synthetic progestin (Austin, 1991).
None of these experiments documented differentiation of the MD into mature FRT
structures on either a morphological or histological level, however. This underscores a
fundamental lack of knowledge on alligator FRT development, as it is unknown when the
alligator MD normally undergoes regional differentiation. In his estrogen treatment study,
Forbes (1938) noted that in juvenile alligators, over 1.5 years old by the end of the dosing
regime, the oviducts of the control animals were completely undifferentiated, displaying
the same simple columnar luminal epithelium and undifferentiated mesenchymal stroma
observed in embryos and neonates (Forbes, 1940). While the oviducts were massively
hypertrophied in treated females, they also lacked adult FRT characteristics; Forbes noted
ciliation and increased height of the luminal epithelial cells and some smooth muscle
differentiation in outer stroma, but no glandular development or distinctive regional
characteristics (Forbes, 1938a). This matches what has been heretofore seen by our
laboratory members in our alligator research – no differentiation of the MD or oviduct in
alligators we have sampled at embryonic, neonatal, or juvenile stages up to 1.5 years of
age. In mammals, the MD differentiates into the FRT structures before birth (humans) or
not long thereafter, with full differentiation of uterine glands completed during puberty
(Yin and Ma, 2005). The age at which alligator MD differentiates into regionalized FRT,
and the signals involved in this process, are thus far unknown.
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1.2.5. Estrogen receptor isoforms and the induction of an unexpected alligator Müllerian
duct phenotype
In 2010 we conducted an experiment to investigate the effects of in ovo treatment
with estrogen receptor (ER) isoform specific agonists on alligator sex determination.
Exposure to exogenous estrogen can induce ovarian development in alligator embryos
incubated at the MPT (Bull et al., 1988; Kohno and Guillette, 2013) and exposure to
estrogenic contaminants can alter sex ratios at an intermediate temperature (Crain et al.,
1997; Milnes et al., 2005), suggesting that an estrogenic signal prior to TSP overrides
the male-determining temperature signal. To better understand the molecular mechanism
involved in this process, we treated embryos with pharmaceutical agents with specific
affinities for the ER isoforms, ERα and ERβ.
There are at least two isoforms of the ER that have been identified in all vertebrate
classes, which have high sequence identity in their DNA binding domains but less so in
their ligand binding domains (Katzenellenbogen et al., 2000b; Thornton, 2001). These
structural differences are borne out in differential affinities between the two isoforms for
exogenous ligands (Li et al., 2012).
Studies in the red-eared slider turtle, another reptile with TSD, showed differential
expression patterns of ERα and ERβ in the developing gonad, and differences in ovarian
localization in response to temperature or stimulation with E2 (Ramsey and Crews, 2009).
This led us to consider the potential roles of these ER isoforms in TSD in the alligator.
Via receptor transactivation assays, we identified pharmaceutical agonists selective
for the alligator ER isoforms. In ovo treatment with the ERα selective agonist propyl
pyrazole triol (PPT) induced ovarian differentiation at the MPT, while treatment with the
ERβ selective agonist WAY 200070 (WAY) did not (Kohno et al., 2015).
In addition to its potential role in gonadal differentiation, the interplay of signaling
between ERα and ERβ appears to be an important regulatory mechanism in the FRT.
10

Mammalian studies suggest that estrogen-mediated cellular proliferation in the uterus
occurs through ERα, as an ERα knockout mouse model displays decreased uterine
growth compared to wild type (Hewitt et al., 2010). Further evidence in multiple estrogen
signaling pathways suggest an antagonistic relationship between the ER isoforms, with
ERβ antagonistically regulating ERα activity (reviewed in Matthews and Gustafsson,
2003). Additionally, ER knockout mouse studies as well as studies using ER-isoform
specific agonists in mice have shown that the FRT anomalies induced by perinatal DES
exposure are mediated through ERα (Couse and Korach, 2004; Nakamura et al., 2008).
In our experiment, in ovo treatment with the ERα selective agonist PPT
unexpectedly induced extreme MD enlargement. Neither treatment with E2 nor with the
ERβ selective agonist WAY at comparable doses had this effect (Kohno et al., 2015).
Altered MD morphology at this level had never previously been observed in our studies.
Even when using substantially higher doses of in ovo administered E2, the only observed
oviductal effect was increased luminal epithelial cell height (Crain et al., 1999).
This finding raised many questions around the role of estrogen signaling in
alligator FRT development. I was intrigued that such a dramatic morphological change
occurred due to selective agonism of one ER isoform, when many other experiments with
endogenous and synthetic estrogens and estrogenic chemicals produced no observable
MD effects. This PPT-induced MD phenotype initiated my dissertation project, as it
provided a model for producing investigable alterations in developing alligator FRT
rooted in altered endocrine signaling.

1.3. Research goal and questions for investigation
The goal of this dissertation research is to characterize the role of estrogen
signaling in the development of the female reproductive tract of the alligator, in
order to provide a better understanding of how exposure to EDCs during critical
developmental windows can disrupt this system.
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The fortuitous discovery of the PPT-induced MD phenotype provided a jumpingoff point for further investigation. Three main questions stemming from this discovery are
addressed in the following research chapters:

1. What are the histological and molecular characteristics of the PPT-induced MD
phenotype, and can they be utilized to inform further exploration into the role of estrogen
signaling in alligator FRT development?

2. Why does only treatment with ERα selective agonist PPT, and not treatment with E2 or
ERβ selective agonist WAY, induce these MD characteristics?

3. Do alligators from a background of contaminant exposure exhibit a different MD
response to PPT treatment than alligators from a reference site?

These questions are addressed in the following experiments based on utilizing the
established model of in ovo treatment with E2 and selective pharmaceutical agonists for
ERα and ERβ, and comparing their effects on alligator MD via histological assessment
and analysis of expression of key genes of interest.
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Fig. 1.1 The adult alligator female reproductive tract is highly regionalized.
Schematic drawing (modified from Guillette, 1992) of the adult alligator FRT external and cross
sectional morphology. Below are representative cross sectional photomicrographs of the three
indicated regions, tube, anterior uterus, and posterior uterus, at 4x (above) and 20x (below)
magnifications. Sections stained with H&E. Scale bars = 100 μm.
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CHAPTER 2:
In ovo treatment with an estrogen receptor alpha selective agonist causes precocious
development of the female reproductive tract of the American alligator
(Alligator mississippiensis)

2.1. Introduction
The American alligator has featured in multiple studies of environmental sex
determination and the effects of environmental endocrine disruptors that have provided
valuable insights into the lasting effects of early developmental exposures (Kohno
and Guillette, 2013; Milnes and Guillette, 2008). Sex determination in the alligator
is temperature dependent, rather than genetic (Ferguson, 1985), which makes it an
interesting experimental model for research involving sexual differentiation, as the sex
of developing embryos can be manipulated in the laboratory via incubation temperature.
Moreover, administration of estrogens or ERα agonists to embryos incubated at the
MPT induces ovarian development (Bull et al., 1988; Kohno et al., 2015; Kohno and
Guillette, 2013). While multiple studies have investigated the effect of estrogens on
ovarian differentiation in reptile species exhibiting TSD, the hormonal influences on the
differentiation of the MD into the mature oviduct (the female reproductive tract structures
including infundibulum, tube and uterus) remains largely unknown. In the alligator, this
differentiation of the oviduct occurs sometime after hatching and before reproductive
maturity, but the actual time point remains undocumented. For the purposes of this study,
the female reproductive tract will be designated “Müllerian duct” in the embryo and
“oviduct” after hatch out.
In birds, which share the Archosaurian evolutionary lineage with crocodilians,
differentiation of the MD is particularly sensitive to estrogenic input. Early studies
documented left oviductal hypertrophy and retention of the right oviduct when immature
chickens were dosed with exogenous estrogens (Munro and Kosin, 1943). In the current
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understanding of the development of the avian oviduct, genetic factors lead to ovarian
differentiation of the left gonad, which produces estrogens that counter the effects of
AMH, leading to oviduct development (reviewed in Hermansson, 2007). Estrogens
are also involved in differentiation of the avian MD. In ovo estrogenic stimulation
induces proliferation of the luminal epithelium and cytodifferentiation and glandular
morphogenesis in the avian oviduct (Andrews and Teng, 1979; Berg et al., 2001).
Several studies suggest that the alligator MD is similarly labile to the influence
of estrogen signaling. In some studies of sex determination in alligators, E2 treatment
of eggs incubated at MPT resulted in 100% ovarian development and “some” oviductal
hypertrophy relative to untreated animals incubated at the FPT (Bull et al., 1988; Lang
and Andrews, 1994). Treatment of eggs incubated at FPT with a synthetic progesterone,
norethindrone, also led to hypertrophied MDs (Austin, 1991). Postnatal estrogenic
treatment of hatchling and juvenile female alligators up to 1.5 years of age has also been
shown to induce oviductal hypertrophy (Austin, 1989; Forbes, 1938a; Forbes, 1938b).
These studies support the hypothesis that the developing alligator FRT is receptive to
estrogen stimulation and is a potential target of disruption by environmental EDCs.
The ER is highly promiscuous, having an affinity for a wide variety of compounds
including endogenous and synthetic estrogens, plant hormones, and EDCs such as
bisphenol A and agricultural pesticides and their metabolites (Katzenellenbogen,
1995). There are two isoforms of ER that have been identified in amniotes, ERα and
ERβ, which have high sequence identity in their DNA binding domains but less so in
their ligand binding domains (Katzenellenbogen et al., 2000a; Katzenellenbogen et al.,
2000b). Mammalian studies of MD differentiation indicate an interplay of estrogen
signaling between the two receptor subtypes, with ERα mediating estrogen-induced
cellular proliferation. ERα knockout mice display decreased uterine growth linked to
dysregulation of insulin-like growth factor-1 (IGF1) (Hewitt et al., 2010). Similarly, ER
knockout mice as well as studies utilizing ER-isoform selective agonists in mice have
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shown that reproductive tract anomalies induced by exogenous estrogen exposure act
through ERα (Couse and Korach, 2004; Nakamura et al., 2008).
Both ERs from the American alligator have been cloned and sequenced (Katsu
et al., 2004; Katsu et al., 2010). As with other vertebrates, alligator ERs show high
specificity for endogenous estrogens in their transactivation (Katsu et al., 2010; Kohno
et al., 2015). Further studies have shown that both receptor subtypes, as well as the
androgen receptor (AR) and progesterone receptor (PGR), are expressed in oviduct of the
juvenile alligator (Moore et al., 2012).
In a previous study, an ERα selective agonist, PPT, induced an unusual MD
phenotype in alligator embryos incubated at the MPT (Kohno et al., 2015). This was of
interest for further investigation, as the embryonic development of the alligator MD is not
well understood, and no previous studies have reported the particular MD phenotype we
observed.
Here we investigated the effects of in ovo stimulation of the ER subtypes with
selective agonists in embryos incubated at the FPT to assess the effects of receptor
subtype-specific estrogen signaling on alligator oviductal development. We also
examined the expression of MD genes involved in steroid hormone signaling and
proliferation induced by estrogenic treatment in the developing female alligator.

2.2. Materials and methods
2.2.1. Egg collection, incubation and treatment
All experiments in this study involving alligators were carried out under the
protocol approved by the Institutional Animal Care and Use Committee at the Medical
University of South Carolina, and all fieldwork was conducted under permits from the
Florida Fish and Wildlife Conservation Commission and the U.S. Fish and Wildlife
Service.
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Alligator eggs were collected from Lake Woodruff National Wildlife Refuge
(De Leon Springs, FL, USA) under Florida Fish and Wildlife Commission permits on
6/15/2012 and 6/21/2012. Upon transportation to our facilities at the South Carolina
Department of Natural Resources Marine Resources Research Institute (Charleston, SC,
USA), eggs were weighed, candled to ascertain viability and placed in nest boxes of
moist sphagnum moss and incubated at 30°C (FPT) in enclosed incubators. An embryo
from each clutch was sampled and staged based on criteria from Ferguson (1985).
Once the embryos had developed to stage 19, as predicted by equation (Kohno
and Guillette, 2013), they were randomly assigned to treatment groups: 0.5 μL/g egg
weight (EW) absolute ethanol; 0.005, 0.05 and 0.5 μg/g EW E2 (Sigma-Aldrich, St.
Louis, MO, USA); 0.05, 0.5, and 5 μg/g EW PPT (Tocris Bioscience, Bristol, UK); and
0.05, 0.5 and 5 μg/g EW WAY 200070 (Tocris). These doses were based on the doses of
PPT and E2 that previously induced ovarian development in embryos at MPT (Kohno et
al., 2015). All compounds were dissolved in absolute ethanol (95% ethanol incubated for
24 hours with molecular sieves). Eggs were weighed and treated by painting the eggshell
surface with the appropriate dose of treatment solution (Crews and Wibbels, 1993).
Embryos were incubated at FPT for the duration of the experiment.
Embryos were sacrificed at stage 27, which is the stage prior to hatching. At time
of collection, eggs were re-weighed, and embryos were weighed and sacrificed. Left and
right gonad-adrenal-mesonephros (GAM) complexes, with attached MDs, were collected
under a dissecting microscope, the right preserved in RNAlater® (Life Technologies,
Grand Island, NY, USA) and the left in 4% paraformaldehyde (PFA) fixative. The fixed
tissues were incubated overnight on a shaker at 4°C. The RNAlater® -preserved tissues
were then stored at -20°C. The PFA-fixed tissues were progressively dehydrated in
methanol/PBST over a 24-hour period and stored in 100% methanol at -20°C.
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2.2.2. Histology
GAM tissues with attached MDs were examined for gross morphological
characteristics under a dissecting microscope. Representative samples were photographed
using a PixeLINK digital camera and the PixeLINK Capture OEM software (Ottowa,
ON, Canada).
The PFA-fixed tissues were further dehydrated through a series of isopropanol and
xylene and paraffin infiltrated using a Leica ASP300 autoprocessor (Wetzlar, Germany),
and embedded into paraffin using a Leica EG1150C embedder. Tissues were serially
cross-sectioned at 7 µm using a Leica RM2255 microtome, and stained with hemotoxylin
and eosin.
Full serial cross sections were examined for a subset of the samples in each
treatment group (n ≥ 5) to determine regions of interest for direct comparison. The
anterior-posterior axis of the GAM was utilized as a metric for assessing regionalization
of the MD. Representative digital photomicrographs were taken with a ProgRes Speed
XT core 5 camera (Jenoptik, Jena, Germany) of a region near the anterior end of the
GAM, and at a region just posterior of the adrenal gland, around the midpoint of the
GAM complex. Using the IMT iSolution Lite software (Martin Microscope Company,
Easley, SC, USA), luminal epithelial cell height was measured at four points in three
separate sections at each of the regions examined (n = 5 samples from each treatment
group).

2.2.3 RNA isolation, cDNA synthesis and quantitative PCR
RNAlater®-preserved MD tissues were manually separated from GAM
complexes under a dissecting microscope and stored at -20°C until RNA extraction.
Whole MDs were homogenized for RNA extraction. Methods for RNA isolation,
cDNA synthesis and qPCR have been previously described (Kohno et al., 2015). RNA
was isolated from tissues using the acid phenol-guanidinium thiocyanate-chloroform
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extraction method followed by further purification using the SV Total RNA Isolation
System with DNase-I treatment (Promega, Fitchburg, WI, USA). RNA concentration
was measured using a Nanodrop Spectrophotometer (Thermo Scientific, Wilmington,
DE, USA) and quality was assessed via denaturing agarose gel electrophoresis. Prior to
cDNA synthesis, RNA was diluted to matching concentrations and used as a template
for quantitative real-time PCR to check for genomic DNA contamination. RNA was
reverse transcribed using the iScript cDNA Synthesis kit (Bio-Rad, Hercules, CA, USA)
per manufacturer’s protocol with 15 µL RNA in 20 µL total reaction volume, and the
resulting cDNA was diluted 1:5 in nuclease-free water.
QPCR was performed using a CFX96 real-time system (Bio-Rad). Reactions were
performed in triplicate using 0.01 U/μl AmpliTaq Gold (Applied Biosystems, Carlsbad,
CA, USA) and an in-house SYBR green reaction mixture consisting of 20mM TrisHCL (pH 7.75), 50mM KCl, 3mM MgCl2, 4% DMSO, 0.5x SYBR Green I (Thermo
Fisher Scientific, Grand Island, NY, USA), 0.5% glycerol, 0.5% Tween 20, 0.2mM
deoxynucleotide mix (Thermo Fisher Scientific), 0.2 µM primer mix (Eurofins Genomics,
Huntsville, AL, USA), and 1/25 volume diluted cDNA.
The thermal cycler program consisted of an initial denaturation step (95°C, 5 min)
followed by 45 cycles of denaturation (95°C, 15 s) and annealing and elongation at an
optimized temperature (45 s). After the final cycle, a dissociation curve was generated for
each reaction to assess the reaction specificity via an incremental heating step (+0.5°C/5 s).
Primer sequences, product size and optimal annealing temperatures are listed in
Table 1. Prior to analysis of unknown samples, the specificity of each primer pair was
confirmed by product sequencing. Plasmid DNA standard curves of known copy number
were generated with these sequenced products. Each 96-well plate of unknown samples
included a standard curve, and all samples, including those of the non-template control
and standard curve, were run in triplicate. Mean expression values of mRNA for each
target gene were normalized to that of ribosomal protein L8 (RPL8). Due to low mRNA
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levels for ESR2, this gene was re-run using full concentration cDNA (not 1:5 diluted) and
normalized to the values for RPL8 with non-diluted cDNA.

2.2.4. Statistical analysis
The effect of treatment on mean luminal epithelial cell height at both regions
histologically examined was analyzed via one-way analysis of variance (ANOVA)
followed by a Tukey’s multiple comparison post-hoc test.
QPCR data were collected and analyzed using CFX Manager version 3.0 software
(Bio-Rad). After determining that expression of RPL8 was not significantly affected by
treatment via one-way ANOVA, expression values of all other genes of interest were
normalized to RPL8. Arcsine-transformed data was used to conduct one-way ANOVA
to calculate the effect of treatment on expression of genes of interest, and outlying
values were removed via ROUT method with a maximum false discovery rate set at 1%.
Significance was set at p < 0.05, and a Tukey’s multiple comparison post-hoc test was
used to detect differences among treatment groups.
All statistical analysis was performed using both JMP12 (SAS Institute, Inc.,
Cary, NC, USA) and Graphpad Prism 6 (Graphpad Software, Inc., LaJolla, CA, USA)
software.

2.3. Results
2.3.1. Gross morphology of the embryonic Müllerian duct is altered by PPT treatment
The reproductive organs of the embryonic female alligator at stage 27 include the
paired GAM and the MDs, simple tubes that run along the distal portion of the GAM,
connected to the GAM by the mesosalpinx, and terminate in the cloaca. Treatment with 5
μg/g EW PPT at FPT produced enlarged MDs, thickened pubis symphysis, and enlarged
cloaca compared to controls. As shown in Figure 2.1, compared with the vehicle control
samples, the MDs of the high dose (5 μg/g EW) PPT-treated tissues were much larger
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in diameter, dwarfing the GAM complex with their size and length, extending farther
anteriorly into the abdominal cavity. While control MDs were relatively straight, simple
tubes that ran alongside the GAM, 5 μg/g EW PPT-treated MDs were so expanded in size
and length that they were tortuous rather than lying flush with the GAM.
Treatment with 0.5 μg/g EW PPT also induced MD enlargement, though it was
not as extreme as the higher dose of 5 μg/g EW PPT, and the low dose PPT treatment
(0.05 μg/g EW) did not induce any observable MD alterations (Fig. 2.1). None of the
samples treated at any of the doses of the ERβ agonist, WAY, or the doses of E2, showed
significant gross morphological differences from the control (Fig. 2.1).

2.3.2. PPT treatment induced glandular development in the Müllerian duct
At stage 27 the embryonic GAM and MD tissues were connected by a
mesosalpinx and were most easily processed for histology as a complex. These GAMMD complexes were serially cross-sectioned and two regions along the anterior-posterior
axis were selected for close histological examination (Fig. 2.2). At this stage, the control
MD was structurally simple, with a central lumen with a simple columnar luminal
epithelium, surrounded by a fibroblastic mesenchymal stroma (Fig. 2.3). There was a
short region around the midpoint of the GAM complex, just posterior to the terminus
of the adrenal gland, in which the epithelial cells lining the oviductal lumen displayed
an increased height (Figs. 2.3B and D). This regional characteristic was displayed in all
samples in all treatment groups examined in this study, so comparative observations were
taken at two regions along the GAM-MD complex, as indicated in Fig. 2.2.
The histological cross sections of the medium (0.5 μg/g EW) and high dose (5
μg/g EW) PPT-treated MDs were strikingly different from all other treatment groups,
as was expected due to the obvious gross morphological differences (Figs. 2.4 and 2.5).
In eight out of 11 medium dose (0.5 μg/g EW) PPT-treated tissues, the MD was greatly
enlarged in width compared to the controls, with hypertrophied stromal cells (Fig. 2.4).
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However, no cellular differentiation was observed in the stroma or the epithelium in
tissues treated at this dose.
More striking characteristics were observed in the high dose (5 μg/g EW) PPT
treatment group, which displayed not only overall MD enlargement, but also cellular
differentiation of the stroma (Fig. 2.5). Multiple glandular structures budded out from
the luminal epithelium, and there was secretory material present in the lumen (Figs.
2.5A and C). Proceeding posteriorly along the oviduct, these glandular structures were
less numerous and there was a greater proportion of connective tissue in the stroma
(Figs. 2.5B and D). None of the other treatment groups, including the 0.5 μg/g EW PPT
treatment group, developed any of these differentiated structures.

2.3.3. PPT treatment induces increased luminal epithelial cell height in the embryonic
alligator Müllerian duct.
The MD luminal epithelium was also altered by PPT treatment. The epithelium of
the MD at stage 27 in the controls was simple columnar (Figs. 2.3A and C), with a region
of greater proliferation and increased cell height near the middle of the GAM complex
(Figs. 2.3B and D). The epithelial cell heights at both the anterior and middle region of
the 5 μg/g EW PPT-treated MDs were significantly higher than all other treatment groups
(p <0.0001, Fig. 6). The high dose (5 μg/g EW) PPT-treated luminal epithelial cells are
also ciliated, a characteristic that none of the other treatment groups displayed (Figs. 2.5C
and D).

2.3.4. PPT treatment alters gene expression in the embryonic Müllerian duct
ERα mRNA expression in MD was reduced nearly threefold by 5 μg/g EW PPT
treatment (Fig. 2.7). ERβ and PGR mRNA levels were very low in embryonic MD of
controls, but PPT treatment significantly increased them at both the medium (0.5 μg/g
EW) and high dose (5 μg/g EW) levels (Fig. 2.7). PGR mRNA was 12-fold higher at the
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medium dose and 25-fold higher at the high dose of PPT-treatment than controls (Fig.
2.7). AR expression in MD was increased threefold by 5 μg/g EW PPT treatment (Fig.
2.7). IGF1 expression in MD was increased five-fold at both 0.5 μg/g EW and 5 μg/g
EW PPT doses (Fig. 2.7).
Expression of IGF1 receptor (IGFR), epidermal growth factor (EGF), EGF
receptor (EGFR) and proliferating cell nuclear antigen (PCNA) were not significantly
altered by the treatments (Fig. 2.8).

2.4. Discussion
The MD phenotype induced by in ovo treatment with 5 μg/g EW PPT was
substantially different from controls and all other treatments in this experiment. The
histological characteristics of these high-dose PPT-treated MD are more similar in
appearance to the vitellogenic adult alligator oviduct than to what has been previously
observed and documented in normal stage 27 alligators incubated at FPT. The mature
alligator oviduct is differentiated into highly specific regions with distinct characteristics
and functions. Three regions are of particular importance: the tube, the anterior uterus
and the posterior uterus. The tubal region has a tall columnar epithelium of ciliated and
microvillous secretory cells and an extensive network of branched acinar glands that
secrete glycosaminoglycans (Bagwill et al., 2009; Palmer and Guillette, 1992). The
anterior uterus secretes protein fibers from branched tubular glands with numerous visible
eosinophilic secretory granules, while the posterior uterus is the site of the shell gland,
and the branched tubular glands have fewer secretory granules than the anterior uterus.
Progressing posteriorly along the oviduct, stromal glands become less pronounced and
there is a greater area of connective tissue, surrounded by layers of smooth muscle.
(Bagwill et al., 2009; Palmer and Guillette, 1992).
While not directly congruent with the adult oviduct, the MDs of the embryonic
alligators treated with 5 μg/g EW of PPT in this study display similar regional
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characteristics. A higher proportion of glands fill the stroma at the anterior end, and these
glands become less prominent moving posteriorly along the tissue. Connective tissue
becomes more obvious in the posterior regions of the MD, and the outer portion appears
to be differentiating into smooth muscle.
While previous studies have shown oviductal hypertrophy following treatment
with estrogens, no studies document glandular differentiation in the immature alligator
oviduct or embryonic MD. Forbes (1938b) noted smooth muscle differentiation in the
outer stroma in the hypertrophied oviducts of 15-month-old alligators injected 3 or more
times a week for 80 days with large doses of EB. This smooth muscular differentiation
increased posteriorly, similarly to the regionalized characteristics in adult oviducts
(Bagwill et al., 2009; Palmer and Guillette, 1992) and in the 5 μg/g EW PPT-treated
MDs in this study. There is only one study in the literature that documents histological
characteristics of hypertrophied oviducts induced by in ovo treatment, in this case with
the synthetic progestin norethindrone (Austin, 1991). Serial cross sections reportedly
showed no regional differences, and the sections adjacent to the end of the adrenal gland
selected for close examination (likely the same area as the mid-GAM sections examined
in our study) showed stromal expansion with no glandular or muscular differentiation
(Austin, 1991). In our studies involving in ovo administration of estrogens and other
endocrine-active compounds to alligators, we have not previously observed precocious
differentiation of the oviduct. Even when using substantially higher doses of in ovo
administered E2, the only observed oviductal effect was increased luminal epithelial cell
height (Crain et al., 1999). To our knowledge, only treatment with the ERα selective
agonist PPT has induced the phenotype of precocious glandular differentiation in the
alligator MD or immature oviduct.
There are several possible modes of action for why PPT and not any other
ER ligands have had this effect on the alligator MD. Considering that PPT is a
pharmaceutical agent, it is possible that its effect is related to its metabolism. All of the
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treatments in this study were administered in a single dose at stage 19. The half-life of
PPT administered to an embryonic alligator via the eggshell surface is unknown, so it
may remain in circulation much longer than E2 and other treatments, causing prolonged
stimulation. The elimination half-time in serum for PPT administered subcutaneously in
adult ovariectomized rats is six hours (Sepehr et al., 2012). We analyzed PPT-induced
effects at stage 27, approximately 38 days after treatment. Thus, the effects of PPT in
this study are not likely to be due to prolonged stimulation. Further investigation into the
pharmacokinetics of PPT in ovo is needed.
While PPT was developed as a selective ERα agonist and was tested specifically
on the alligator ERα via transactivation assay (Kohno et al., 2015), it is possible that
it may have off-target effects on other steroid hormone receptors. As previously noted,
in ovo treatment with a synthetic progestin induced oviductal hypertrophy (Austin,
1991), so it is possible that PPT may have affinity for the PGR. Expression of PGR was
significantly increased by both 0.5 μg/g EW and 5 μg/g EW PPT treatment in our study.
However, in the chicken embryo, oviductal expression of PGR increases upon estrogen
stimulation and administration of progesterone inhibits estrogen-induced glandular
differentiation in the embryonic chicken oviduct (Dougherty and Sanders, 2005; Oka and
Schimke, 1969a, b; Palmiter and Wrenn, 1971). This strongly suggests an antagonistic
role for progesterone in regulating estrogen stimulation in the developing avian oviduct.
The developing alligator oviduct may be similarly regulated; further investigations are
required to test this hypothesis.
We also investigated the expression of growth factors known to be involved in
estrogen-induced proliferation in the FRT, EGF and IGF-1 (DiAugustine et al., 1988;
Murphy et al., 1987), and their respective receptors. While there were no differences in
EGF expression among the treatment groups, both 0.5 μg/g EW and 5 μg/g EW PPT
treatment induced a significant increase in IGF1 expression. The PPT-induced increase
in IGF1 and not EGF may be due to the more central role of IGF-1 in the proliferation of
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the avian and reptilian oviduct. In the avian oviduct, oviductal IGF1 expression increases
in direct correlation with increasing oviductal size in immature Japanese quail (Fu et al.,
2001) and it increases robustly following DES injection (Kida et al., 1994). Similarly,
in reptiles, administration of IGF-1 via slow-release pellet induced a greater degree of
oviductal proliferation in ovariectomized geckos than EGF (Cox, 1994). IGF-1 is known
to be increased in the vitellogenic adult alligator oviduct (Cox and Guillette, 1993), so
it is probable that IGF-1 is the primary mitogen involved in estrogen-induced oviductal
proliferation in the alligator.
Taken all together, these results strongly suggest that the observed effect of
PPT on the developing alligator oviduct is in fact due to its selective stimulation of
ERα. Studies of the role of estrogens in the development of the FRT in mammals and
birds show that the proliferative and differentiative effects of estrogen are mediated
through ERα. In ovo exposure to DES results in rapid stromal hypertrophy and glandular
formation in the chicken oviduct (Kohler et al., 1969), and the effects of DES have been
shown to be mediated through ERα in the mammalian FRT (Couse and Korach, 2004;
Nakamura et al., 2008). Moreover, in ovo exposure to PPT results in disrupted oviductal
differentiation in female chickens, including hypertrophy and retention of the right
oviduct, and partial oviductal development in males (Mattsson, 2008; Mattsson et al.,
2011). Thus, estrogens play an important role in the normal differentiation of the avian
FRT, but selective stimulation of ERα results in disrupted development. Murine studies
of estrogen-regulated pathways suggest an antagonistic relationship between the estrogen
receptor subtypes, with ERβ antagonizing ERα activity (Matthews and Gustafsson,
2003). PPT treatment seems to result in excess stimulation of oviductal proliferation,
without ERβ signaling pathways to keep it in check.
In conclusion, stimulation of ERα in ovo at FPT induced significant enlargement
of the alligator MD with precocious development of secretory glands and connective
tissue differentiation similar to characteristics of mature adult oviduct. Increased
26

expression of ERβ, progesterone receptor, androgen receptor and insulin-like growth
factor 1 might explain the phenomena in the MD. These results suggest that the
embryonic alligator MD is labile to exogenous estrogen signaling through ERα, and
ligands that selectively agonize ERα can disrupt normal FRT development.
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Table 1. Primers for quantitative real-time PCR
Primer
name
ACTβ
AR
EEF1
EGF
EGFR
ESR1
ESR2
IGF1
IGF1R
PCNA
PGR
RPL8

Product Annealing
Size
Temp.
Accession Number
(bp)
(°C)

Sequence 5' to 3'
GAGGGTTTTAGGTGTAACTGCTTG
ACATACTGGCACCGCTTTTC
GCCAGACTCCTTCTCCAACC
TCTCCATCCCATGGCGAAAA
CGTTCTGGTAAGAAGCTGGA
TGACACCAACAGCAACAGTC
GACCTGGTTTGGCCTAGTGG
ACGTACCCTGTTTTGGCTGG
ACGAAGACAAATATGCACTGG
GAGACCATCCTGTGGAATGA
AAGCTGCCCCTTCAACTTTTTA
TGGACATCCTCTCCCTGCC
CCAAAGAGCCCATGGTGTGA
ACCATTTGCAATGGGACTTGT
TCAGTTCGTATGTGGAGACAGA
CCACTATCCCCTTGTGGTGT
TTGTTCGATGGCAACAACAGC
GACTTTCCGGTACTCTGCCT
AGCAGAAGACAATGCAGACAC
TGCATCTCCAATATGGCTTAG
AGCAGTTGGATTGCGCCAGAA
TCAGTGCCCGAGACTGAAGA
CTCTCACAATCCTGAAACCAA
GTTTGTCAATACGACCTCCAC

195

65

NM_001286847.1,
GCA_000281125.1*

177

62

LC012894.1

169

62

XM_006269752.2

243

64

XM_014593525.1

163

62.4

XM_014602495.1

71

64

NM_001287274.1

114

64

NM_001287264.1

92

64

JQ693409.1

230

66.4

XM_014605993.1

198

64

XM_006267175.2

143

64

AB115911.1

115

62

XM_006266675.2

* primer set designed using alignment of A. sinensis sequence with A. mississippiensis
genome (St John et al., 2012)
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Fig. 2.1. Gross morphology of embryonic alligator GAM complex and Müllerian duct at stage 27.
Stage 27 alligator GAM and MD treated with (A) 0.5 μL/g EW EtOH (vehicle control); (B) 0.005
μg/g EW E₂; (C) 0.05 μg/g EW E₂; (D) 0.5 μg/g EW E₂; (E) 0.05 μg/g EW WAY; (F) 0.5 μg/g
EW WAY; (G) 5 μg/g EW WAY; (H) 0.05 μg/g EW PPT; (I) 0.5 μg/g EW PPT; and (J) 5 μg/g EW
PPT. All scale bars indicate 3 mm. All tissues shown in lateral view; tissue orientation in (A)
indicated by the terms anterior, posterior and ventral is consistent in all other images. Arrow
heads indicate Müllerian duct.
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Fig. 2.2. Schematic of embryonic alligator GAM and Müllerian duct at stage 27.
Dorsal view of the average stage 27 alligator GAM and Müllerian duct indicating where cross sections
were observed. (Modified from Deeming et al., 1988). Dashed lines indicate where along the
anterior-posterior axis cross sections were examined for histological analysis. A, adrenal gland; G,
gonad; M, mesonephros; Md, Mülllerian duct.
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Fig. 2.3. Histology of Müllerian duct and GAM complex at stage 27 in controls.
Representative cross sections of Müllerian duct and GAM complex at stage 27 on the anterior
plane (A) and the posterior plane (B) as shown in Fig. 2. Boxed MDs in A and B are shown with
higher magnification in C and D. The egg at FPT was treated with 0.5 μL/g EW EtOH (vehicle
control) at stage 19. A, adrenal gland; G, gonad; M, mesonephros. Scale bars indicate 100 μm.

31

Fig. 2.4. Histology of Müllerian duct and GAM complex at stage 27 in medium-dose PPT-treated group.
Representative cross sections of Müllerian duct and GAM complex at stage 27 on the anterior
plane (A) and the posterior plane (B) as shown in Fig. 2.2. Boxed MDs in A and B are shown
with higher magnification in C and D. The egg at FPT was treated with 0.5 μg/g EW PPT in
EtOH at stage 19. A, adrenal gland; G, gonad; M, mesonephros. Scale bars indicate 100 μm.
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Fig. 2.5. Histology of Müllerian duct and GAM complex at stage 27 in high dose PPT-treated group.
Representative cross sections of MD and GAM complex at stage 27 on the anterior plane (A) and
the posterior plane (B) as shown in Fig. 2.2. Boxed portions of MDs in A and B are shown with
higher magnification in C and D. The egg at FPT was treated with 5.0 μg/g EW PPT in EtOH at
stage 19. A, adrenal gland; G, gonad; M, mesonephros. Scale bars indicate 100 μm.
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Fig. 2.6. Luminal epithelial cell heights in the stage 27 embryonic alligator oviduct.
Mean cell heights of the MD simple columnar luminal epithelium across the treatment groups for
the anterior cross sectional plane (left) and the more posterior cross sectional plane (right). Triangles
under bars indicate treatment dose, low to high. Error bars indicate standard error of mean. p-values
given for one-way ANOVA. Letters above columns indicate significantly different groups by
Tukey’s post-hoc test.
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Fig. 2.7. Expression of steroid hormone receptors and IGF-1 in alligator Müllerian duct at embryonic stage 27.
Expression values reported as relative expression normalized to ribosomal protein L8 (RPL8).
Triangles under bars indicate treatment dose, low to high. Error bars indicate standard error mean.
p-values based on one-way ANOVA. Letters above bars indicate significantly different groups based
on Tukey’s posthoc test.
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Fig. 2.8. Expression of growth factors and proliferation marker in alligator Müllerian duct at stage 27.
Expression values reported as relative expression normalized to RPL8. Triangles under bars
indicate treatment dose, low to high. Error bars indicate standard error mean. p-values based on
one-way ANOVA.
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CHAPTER 3:
Investigations into the contrasting effects of treatment with estradiol-17β and
estrogen receptor selective agonists on the development of the alligator Müllerian
duct: ligand persistence and unbalanced receptor isoform signaling

3.1. Introduction
We have previously reported that in ovo treatment with the ERα-selective agonist
PPT induced a phenotype of precocious development in the embryonic alligator MD (ch.
2 and Doheny et al., 2016). Estrogen-induced cytodifferentiation and glandulogenesis is
well-studied in the developing avian FRT (Dougherty and Sanders, 2005; Kohler et al.,
1969). Based on their shared Archosaurian lineage and similar adult FRT characteristics
(Palmer and Guillette, 1992), it is a reasonable assumption that the process of
differentiation of MD to FRT in alligators and birds should be similar. However, estrogeninduced glandulogenesis had not previously been documented in the alligator MD.
Our studies are the first to show that this phenotype can only be induced with an ERα
selective agonist.
The processes of cytodifferentiation in the developing FRT of the alligator have
not been previously investigated, neither following treatment with exogenous hormonally
active compounds nor under normal conditions. The timepoint at which the alligator MD
differentiates from a uniform structure to the regionalized structures of the mature FRT
under normal conditions is not yet reported; it must occur at some point later than 1.5
years of age, after it becomes logistically difficult to maintain alligators in the laboratory.
In contrast, the FRT is regionally differentiated at birth or not long thereafter in mammals
(Yin and Ma, 2005) and birds (Dougherty and Sanders, 2005). Embryonic PPT treatment
offers a model for investigating these processes in the alligator MD. We have shown that
when PPT treatment is administered prior to the TSP, the alligator MD has developed
glandular structures in a regionalized pattern by stage 27, just prior to hatchout.
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Investigation of MD characteristics at several stages post-treatment could offer insight
into the processes involved in this cytodifferentiation.
We have hypothesized that the effects of PPT on alligator MD are likely due
to its selective activation of ERα over ERβ. Studies of estrogen receptor isoformspecific knockout mouse models suggest that ERα is necessary for proliferation and
differentiation of the uterus, while ERβ plays a regulatory role, attenuating the effects
of ERα (Weihua, Saji et al. 2000; Matthews and Gustafsson 2003). In our research, the
differentiated alligator MD phenotype has only occurred with PPT treatment and not with
E2 treatment or treatment with ERβ selective agonist WAY, suggesting that the receptor
isoforms may have similar roles in alligator FRT as in mammals. PPT treatment induced
proliferation and differentiation in alligator MD, while activation of both receptors via
treatment with the exogenous ligand, E2, did not. Half maximal effective concentration
(EC50) values measured in receptor transactivation assays showed that E2 is more
selective for ERα than ERβ, but PPT exhibits negligible activation of ERβ (Kohno et al.,
2015). Therefore, we suggest that the difference in MD phenotype following treatment
with E2 versus PPT is due to an imbalance in signaling through the ER isoforms, with
PPT activating ERα in the absence of ERβ.
However, there is a second hypothesis for the differential effects of PPT and
E2 on alligator MD: that the pharmaceutical agonist PPT has a longer half-life than the
native ligand. Our experiments utilized single dose administration, so a difference in
metabolism of the treatment compounds could result in a difference in the duration of
receptor activation. The half-life of estradiol 17-β is less than 24 hours (12-17 hours in
humans) (Norris, 1997). As previously addressed in ch. 2, the half-life of PPT in adult
ovariectomized rats is six hours (Sepehr et al., 2012), but the actual pharmacokinetics
of this compound administered to alligator embryos via eggshell surface painting is
unknown and beyond the scope of this investigation. Xenobiotic metabolism is not
well-studied in wildlife in general, but it is known to often vary greatly from what
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is seen in model organisms, as it is influenced by multiple factors such as body size,
thermoregulation and dietary makeup (Hutchinson et al., 2014).
The goal of the following experiments was to investigate more deeply the
mechanism of PPT-induced MD differentiation. We first compared the effects of PPT
treatment and E2 treatment on the alligator MD to normal male and female temperature
development at four embryonic developmental stages, to better characterize the process
of PPT-induced cytodifferentiation.
We tested the half-life hypothesis by comparing the effects of in ovo E2 and PPT
treatment on alligator MD with those of estradiol benzoate (EB), an estrogen ester. While
pharmacokinetics of EB in alligator embryos are unknown, clinical studies in humans
have shown that estrogen esters have a longer half-life than E2 but similar receptor
kinetics (Oriowo et al., 1980).
If an imbalance in receptor isoform signaling is a contributing factor in the PPTinduced MD phenotype, we hypothesized that treating with selective agonists for both
ERα and ERβ should have a “rescue” effect on alligator MD, producing a phenotype
similar to vehicle-treated controls or to that produced by E2 stimulation. We thus
compared the effects of PPT, E2, WAY, and two combinatorial treatments of PPT and
WAY on alligator MD.

3.2. Materials and methods
3.2.1. Egg collection and incubation
All experiments in this study involving alligators were carried out under the
protocol approved by the Institutional Animal Care and Use Committee at the Medical
University of South Carolina. Alligator eggs were collected from Lake Woodruff National
Wildlife Refuge under Florida Fish and Wildlife Commission permits on 6/22/2011 and
on 6/20/2013. Upon transportation to our facilities at the South Carolina Department of
Natural Resources Marine Resources Research Institute, eggs were weighed, candled to
39

ascertain viability and placed in nest boxes of moist sphagnum moss and incubated at
30°C (FPT) in enclosed incubators. An embryo from each clutch was sampled and staged
based on criteria from Ferguson (1985).

3.2.2. Treatment and tissue collection
The designs for the experiments detailed in this chapter are graphically depicted
in Fig. 3.1. For the first experiment, conducted on eggs collected in 2011, once the
embryos had developed to stage 19, they were randomly assigned to treatment groups:
0.5 µL/g EW ethanol, 0.5 µg/g EW E2 (Sigma-Aldrich, St. Louis, MO, USA), or 5 µg/g
EW PPT (Tocris Bioscience, Bristol, UK), doses based on previous experiments. Stock
treatment solutions were prepared by dissolving compounds in absolute ethanol (95%
ethanol incubated for 24 hours with molecular sieves). Eggs were weighed and treated by
painting the surface with the appropriate dose of treatment solution. Embryos assigned to
the FPT control group were returned to 30°C incubation, but all other treatment groups
were transferred to incubation at the MPT, 33°C.
Embryos were randomly assigned to be collected at developmental stages
21, 23, 25 and 27. When the appropriate time point arrived for collection, based on
a developmental equation (Kohno and Guillette, 2013), eggs were re-weighed, and
embryos were weighed and sacrificed. GAM complexes, with attached MDs, were
collected, one placed in RNAlater® (Life Technologies, Grand Island, NY, USA) and
one in Bouin’s fixative, alternating between samples to randomize which side was used
for which analysis type. The fixed tissues were incubated for 24 hours on a shaker at 4°C.
The RNAlater® -preserved tissues were then stored at -20°C. The Bouin’s-fixed tissues
were transferred to lithium-saturated 70% ethanol and stored at 4°C.
For the second experiment, conducted on eggs collected in 2013, embryos were
incubated in the laboratory until stage 19, and then assigned randomly into treatment
groups: 0.5 µL/g EW EtOH, 0.5 µg/g EW E2, 0.5 µg/g EW EB (Sigma-Aldrich, St.
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Louis, MO, USA), 5 µg/g EW WAY, 0.5 µg/g EW PPT, 5 µg/g EW PPT, or combinatorial
treatments of PPT and WAY, 0.5 µg/g EW PPT + 5 µg/g EW WAY and 5 µg/g EW PPT
+ 5 µg/g EW WAY (see Fig. 3.1 for design schematic). Treatments were prepared and
applied as described above, and all eggs were incubated at FPT for the duration of the
experiment.
All embryos were sacrificed at stage 27 and GAM/MD complexes collected
as described above, the right preserved in RNAlater® and the left in 4% PFA. After
overnight incubation at 4°C on a shaker, the RNAlater®-preserved tissues were then
stored at -20°C. The PFA-fixed tissues were progressively dehydrated in methanol/PBST
over a 24-hour period and stored in 100% methanol at -20°C.

3.2.3. Histology
Preserved tissues were examined under a dissecting microscope and photographed
using a PixeLINK digital camera and the PixeLINK Capture OEM software.
GAM/MD complexes were dehydrated through graded isopropanol and paraffin
infiltrated using a Leica ASP300 autoprocessor, and paraffin embedded using a Leica
EG1150C embedder. 2011 tissues were serially cross-sectioned at 7 µm using a Leica
RM2255 microtome. Slides were stained using a modified Masson trichrome stain
(Humason, 1979). Serial cross sections from 5 samples per treatment per stage were
examined for morphological characteristics. A subset of slides from stage 27 were
stained using a combination McMannus’ Periodic Acid Schiff’s (PAS)/ Alcian blue
(AB) technique with pH 2.5 AB (Bancroft and Gamble, 2008) to examine histochemical
profiles.
The 2013 samples were serially cross-sectioned or serially lateral-sectioned at
8 µm using a Leica manual rotary microtome, and stained with hemotoxylin and eosin
using a Leica Autostainer XL with a Leica CV5030 coverslipper.
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For each treatment group, five samples were examined in full, 2-3 as serial cross
sections and 2-3 as serial lateral sections.
Representative digital photomicrographs were taken with a ProgRes Speed XT
core 5 camera (Jenoptik, Jena, Germany).

3.2.4. Sexing of embryos
At stages 25 and 27, the embryos were sexed based on gonadal characteristics,
as described by Smith and Joss (1993). Stage 21 and 23 gonads were too ambiguous for
definitive sexing. Two stage 27 MPT- incubated vehicle control embryos were classified
as female based on gonadal characteristics, so they were removed from all further
analysis to not skew results.

3.2.5. RNA isolation, reverse transcription and quantitative PCR
For the 2011 samples, RNA isolation and reverse transcription and QPCR were
performed according to methods detailed in chapter 2. RNAlater® -preserved MD
tissues were manually separated from GAM complexes under a dissecting microscope
and stored at -20°C until RNA extraction. For three of the stage 27 vehicle control
MPT samples, MD was fully or partially regressed, so these samples were omitted from
further analysis. Whole MDs were homogenized and RNA isolated from tissues using
the acid phenol-guanidinium thiocyanate-chloroform extraction method followed by
further purification using the SV Total RNA Isolation System with DNase-I treatment
(Promega, Fitchburg, WI, USA). RNA concentration was measured using a Nanodrop
Spectrophotometer (Thermo Scientific, Wilmington, DE, USA) and quality was assessed
via denaturing agarose gel electrophoresis. Prior to cDNA synthesis, RNA was diluted to
matching concentrations and used as a template for quantitative real-time PCR to check
for genomic DNA contamination. RNA was reverse transcribed using the iScript cDNA
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Synthesis kit (Bio-Rad, Hercules, CA, USA) per manufacturer’s protocol with 15 μL
diluted RNA in 20 μL total reaction volume, and the resulting cDNA was diluted 1:5 in
nuclease-free water.
This protocol was slightly modified for the 2013 samples. Whole MDs (n=8 per
treatment group) were homogenized for RNA extraction via the SV Total RNA Isolation
System with DNase-I treatment (Promega). RNA concentration and quality was assessed
as described, then RNA was diluted to matching concentrations. Reverse transcription
was performed using the High-Capacity cDNA Reverse Transcription Kit with RNase
Inhibitor (Applied Biosystems, Foster City, CA, USA) per manufacturer’s protocol, using
10 μL diluted RNA in 20 μL total reaction volume, and the resulting cDNA was diluted
1:5 in nuclease-free water.
QPCR was performed using a CFX96 real-time system (Bio-Rad). Reactions were
performed in triplicate using 0.01 U/μl AmpliTaq Gold (Applied Biosystems, Carlsbad,
CA, USA) and an in-house SYBR green reaction mixture described in chapter 2, and 1/25
volume diluted cDNA. The thermal cycler program consisted of an initial denaturation
step (95°C, 5 min) followed by 45 cycles of denaturation (95°C, 15 s) and annealing
and elongation at an optimized temperature (45 s). After the final cycle, a dissociation
curve was generated for each reaction to assess the reaction specificity via an incremental
heating step (+0.5°C/5 s).
Primer sequences, product size and optimal annealing temperatures are listed in
Table 1 (pg. 28). Primer specificity was assessed as described in chapter 2.

3.2.6. Statistical analysis
QPCR data were collected and analyzed using CFX Manager version 3.0
software. For the 2011 samples, three internal control genes, EEF1, ACTB, and
RPL8, were assessed, but no single internal control gene was appropriate for use as a
normalization factor, as all three showed significant effects of treatment via one-way
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ANOVA. For normalization of QPCR values, a normalization factor (NF2) was calculated
based on the geometric mean of all three internal control genes using the geNORM
analytical tool (Vandesompele et al., 2002). Absolute copy number of each target gene
was divided by NF2 and reported as relative expression. These normalized expression
values were used to conduct one-way ANOVA to calculate the effect of treatment on
target genes at each of the four developmental stages, and outlying values were removed
via ROUT method with a maximum false discovery rate set at 1%. Significance was set at
p < 0.05, and a Tukey’s multiple comparison post-hoc test was used to detect differences
among treatment groups.
For the 2013 sample set, expression of ACTB was not significantly affected by
treatment via one-way ANOVA, so expression values of all other genes of interest were
normalized to ACTB. Data were log-transformed to achieve homogeneity of variance.
One-way ANOVA was utilized to calculate the effects of treatment on expression levles
of genes of interest. Outlying values were removed by examination of a residual plot and
ROUT method with a maximum false discovery rate set at 1%. Significance was set at p
< 0.05, and a Tukey’s multiple comparison post-hoc test was used to detect differences
among treatment groups.
All statistical analysis was performed using both JMP12 and Graphpad Prism 6
software.

3.3. Results
3.3.1. Treatment effects on morphological characteristics of Müllerian duct
As seen previously (Kohno et al., 2015), PPT treatment at MPT induced
significant MD enlargement, while E2 treatment did not. This enlargement was already
apparent at stage 23 and became increasingly more pronounced at later stages (Fig. 3.2).
At stage 27 in the MPT vehicle control samples, complete MD regression was observed
in two samples, and partial MD regression in 5 samples.
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For the 2013 samples, the morphological characteristics of MD of the vehicle
control samples and those treated with 0.5 µg/g EW E2, 5 µg/g EW WAY, and the 0.5
µg/g EW and 5 µg/g EW doses of PPT at FPT were identical to what has previously
been documented for these treatments in chapter 2. There were no observable gross
morphological differences between MD treated with E2 or EB.
Contrary to our hypothesis, the co-treatment with WAY did not alter the PPTinduced MD phenotype. The combined 0.5 µg/g EW PPT + 5 µg/g EW WAY treated
MDs were similar to those treated with 0.5 µg/g EW PPT, somewhat enlarged compared
to the controls. The combined 5 µg/g EW PPT + 5 µg/g EW WAY treated MDs were
similar to the 5 µg/g EW PPT treated MDs, massively hypertrophied compared to the
controls. The hypertrophied MDs from these treatment groups were weighed prior to
RNA extraction for proper calculation of reagents, and there was no difference in mean
MD mass (5 µg/g EW PPT mean = 51.38 7.84 mg, 5 µg/g EW PPT + 5 µg/g EW WAY
mean = 43.25 6.05 mg, two-tailed t-test p = 0.43).

3.3.2. Histological characteristics of the gonads and determination of sex
For the 2011 samples, gonadal morphology was examined at stages 25 and 27 to
sex embryos. At stages 21 and 23, gonadal morphology was too ambiguous to determine
sex. The defining characteristics for identifying testis differentiation in alligator are
well-defined medullary sex cords with enlarged cells, and the defining characteristics for
ovarian differentiation are lacunae in the medulla and a well-defined cortex with germ
cells (Smith and Joss, 1993). Treatment with E2 and PPT induced ovarian formation
at MPT in all stage 25 and stage 27 embryos. E2-treated gonads were morphologically
similar to those of the FPT vehicle control samples, but PPT-treated gonads showed
structural differences, with larger lacunae and less cortical definition than controls and
E2-treated gonads (Fig. 3.3).
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As described in the methods section, all but two of the MPT stage 25 and stage
27 vehicle control gonadal samples showed well-defined sex cords, the main testicular
characteristic identifiable at these stages (Fig. 3.3). These stage 27 MPT control samples
with ovaries were removed from further analysis. This and other incidences of females
occurring despite incubation at MPT throughout the canonical TSP inspired a study
in our research group that determined the window of thermosensitivity in alligators
is longer than previously documented (McCoy et al., 2015). The feminized males in
this study were from a clutch collected from the field at an earlier developmental stage
and thus held longer at the FPT than others, which likely influenced their gonadal sex
determination in a female direction.

3.3.3. Treatment effects on Müllerian duct histology
For the 2011 samples, MD structure was similar for FPT control samples and
MPT E2-treated samples across all the stages examined, displaying the simple columnar
luminal epithelium and fibroblastic mesenchymal stroma previously characterized in
chapter 2.
At stage 21, the MPT PPT-treated samples were not distinctly different
histologically from the FPT controls, aside from enlarged size due to some stromal
expansion (Fig. 3.4). By stage 23, this stromal expansion in the MPT PPT-treated MDs
was much more apparent and involved hypertrophy of the stromal cells due to imbibition
(Fig. 3.4). At stage 25, there was glandular formation along the luminal epithelium of
these MPT PPT-treated MDs (Fig. 3.4).
The stage 27 MPT PPT-treated tissues displayed the same characteristics
documented in ch 2. With the use of modified trichrome stain, the formation of
connective and muscular tissues in the periphery of the stroma was evident, as connective
tissue stains green and muscular tissue red (Fig. 3.4). At stage 27 in the MPT control
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samples, complete MD regression was observed in two samples and partial MD
regression in 5 samples.
As with the FPT samples characterized in ch. 2, stage 27 MPT PPT-treated MD
in this experiment showed anterior-posterior regionality. The epithelium of more anterior
regions of the MD was expanded with glands (Fig. 3.5A), while more posterior regions
had fewer glands and more connective tissue and smooth muscle differentiation (Fig. 3.5
B). These regions also stained differently with AB/PAS. In the more anterior region, the
luminal epithelium is positive for AB, while the glands are PAS positive (Figs. 3.5 C and
3.5 E), and in the more posterior region, the staining was less intense in general but the
epithelium was positive for both AB and PAS, while the glands were only AB positive
(Figs. 3.5 D and 3.5 F).
In the 2013 samples, as seen with morphological characteristics, the histological
characteristics of previously examined treatments recapitulated what has been previously
described in chapter 2. The EB-treated MD displayed similar characteristics to the E2treated and control tissues. There were no observable histological differences between 0.5
μg/g EW PPT-treated MD and the MDs treated with combined 0.5 μg/g EW PPT + WAY,
and no observable differences between the 5 μg/g EW PPT-treated MDs and combined 5
μg/g EW PPT + WAY samples.
Lateral sectioning of a subset of samples confirmed previous observations on
anterior-posterior regional differences in the stage 27 alligator MD treated with 5 μg/g
EW PPT at FPT (Fig. 3.6). At the anterior end, the stroma of the enlarged MD was
densely packed with secretory glands. Moving posteriorly, there were fewer glands and
the stroma was made up of irregular cells and loose connective tissue.

3.3.4. Treatment effects on expression of key genes in Müllerian duct
In the 2011 sample set, at MPT, PPT affected expression of key genes in MD at
all stages sampled. For the steroid hormone receptors (SHRs) analyzed, overall, PPT
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treatment resulted in decreased expression of ESR1 and increased expression of ESR2,
PGR, and AR (Fig. 3.7). At stage 21, ESR1 expression was significantly reduced in PPTtreated MD compared to FPT controls, but not compared to E2-treated MD. At stages 23
and 25, however, ESR1 expression was similar in MPT and FPT controls and E2-treated
MD, while it was significantly decreased in PPT-treated MD. At stage 27, this trend was
not quite as extreme, but ESR1 expression was still significantly lower in PPT-treated
tissues than in FPT controls.
ESR2 expression was very low in MD across all stages and treatments, and at
stage 21 there were no significant differences in expression among the treatments. In
MPT PPT-treated MD, ESR2 expression increased over the developmental time course,
and was significantly higher than FPT controls at stages 23, 25 and 27. PGR expression
was significantly higher in PPT-treated MD than all other treatments at every stage
sampled. Expression of AR was significantly higher in PPT-treated tissues than all other
treatments at stages 21, 23 and 25, but at stage 27 AR expression in PPT-treated MD
decreased to a level similar to E2-treated and MPT vehicle control MDs.
Other key genes of interest analyzed were the growth factors EGF and IGF1, and
proliferation marker PCNA (Fig. 3.8). There were no statistically significant differences
in EGF expression across the treatments at stages 21, 23, or 27, but at stage 25 it was
significantly reduced in PPT-treated tissue. IGF1 was significantly increased in PPTtreated MD compared to all other treatments at stages 21, 23 and 25, and at stage 27 it
was significantly higher than in FPT control MD but not compared to MPT control or
E2-treated tissues. Differences in PCNA expression were only observed at stage 25, when
it was significantly higher in PPT-treated tissue compared to MPT controls but not to FPT
controls or E2-treated MD.
The gene expression results for the 2013 samples at FPT follow similar patterns to
what has previously been seen with these treatments (Fig. 3.9). When directly comparing
the effects of EB vs. E2 on the expression of the transcripts assessed, the only significant
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difference was with PGR, for which the expression level is nearly 2.5-fold greater with
EB treatment than E2 treatment. EB treatment also increased transcript levels of ESR2 and
AR slightly more than E2, although this was not statistically significant (Fig. 3.9).
The combination treatments, adding WAY to PPT, were expected to attenuate the
effects of PPT treatment alone, but this did not appear to be the case at the level of SHR
gene expression. Effects of adding 5 µg/g EW WAY to 0.5 µg/g EW PPT and 5 µg/g EW
PPT on the expression levels of the genes investigated were not significantly different
than these doses of PPT alone on ESR1, ESR2, PGR and AR. There was, however, a
significant difference between the treatments in IGF1 expression. There was nearly a
twofold decrease in IGF1 in the combination treatments compared to the PPT treatments
alone.

3.4. Discussion
The multi-stage sampling experiment provided a more in-depth look at the
process of MD differentiation induced via PPT treatment. Alligator embryos develop
from stage 19, the time of experimental dosing, to stage 21, the first sampling time
point, in just 5 days at MPT (Kohno and Guillette, 2013), and already at this point PPTtreated MDs displayed significant differences in the expression of key genes. There
were no observable morphological or histological changes in PPT MDs at this stage,
but PPT-induced MD phenotypic differences became more exaggerated as development
progressed.
The pattern of histological changes in the PPT-treated MD is similar to what
has been seen in foundational studies on the differentiation of the avian oviduct, in
which immature chick oviduct was treated with exogenous estrogens. Within 24 hours
of subcutaneous injection with DES, the left oviductal magnum of 5-day-old chicks
demonstrates substantial stromal hypertrophy due to edema (Kohler et al., 1969), similar
to the stromal expansion seen at stage 23 in PPT-treated alligator MD.
49

In DES-treated chick luminal epithelium, the mitoses increase and the cells
elongate, nuclei enlarge and nucleoli hypertrophy, and the cells differentiate into ciliated
and goblet secretory cells. Secretory glands appear by day 4 as invaginations of the
epithelium and by day 9 these glands expand into the stroma, while stromal cells at the
periphery of the MD differentiate into bundles of smooth muscle (Kohler et al., 1969).
The precocious glandular formation in PPT-treated alligator was first detectable at stage
25, in which a small number of glands appear, forming from invagination of the luminal
epithelium. At stage 27, these glands expand into the stroma in anterior regions of the
MD, and the periphery of the MD shows smooth muscle differentiation.
Differential histological staining utilized in this experiment supports the
observations of regionalized differentiation of the PPT-treated MD. At stage 27, the
PPT-treated alligator MD stained positively with AB and PAS, indicating the presence
of mucopolysaccharide secretory products. PAS stains tissues magenta in the presence
of a variety of mucin polysaccharides, particularly glycosaminoglycans, while AB
selectively stains acidic mucins (Bancroft and Gamble, 2008). In the adult alligator
oviduct, secretory products vary regionally and with reproductive status. The secretory
epithelia stains positively with AB for glycosaminoglycans in a regional fashion: staining
is most intense in the tube, slightly less intense in the anterior uterus and very limited in
the posterior uterus (Palmer and Guillette, 1992). A similar pattern was seen in the stage
27 PPT-treated MD: the luminal epithelium was positive for AB, and this was seen most
clearly in the anterior region.
In reproductively active female alligators, between mating and oviposition,
the oviductal luminal epithelium of the tube and anterior uterus, as well as the tubal
glands, stain positively for PAS (Bagwill et al., 2009). PAS staining was not detected
very strongly at all in the stage 27 PPT-treated MD epithelium, but it was strong in
the glands of the anterior region, decreasing posteriorly. Taken together, the AB/PAS
staining patterns seen in stage 27 PPT-treated alligator MD share some similarities
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to those in reproductively active adult alligator FRT. This supports the idea that PPTinduced cytodifferentiation in the embryonic alligator MD follows a regionalized pattern
reminiscent of the highly regionalized adult FRT.
These histological similarities do not necessarily indicate that PPT-induced MD
differentiation exemplifies the normal process of MD differentiation in the alligator. The
hypertrophy of the PPT-treated MD stroma is indicative of edema, and smooth muscular
differentiation of this tissue is highly disorganized. There are also clear irregularities in
the glandulogenesis of the epithelium. Until normal FRT differentiation in alligators can
feasibly be investigated, however, the PPT-treated MD model still provides valuable
information about this process.
On a molecular level, SHR expression is rapidly affected by PPT treatment in
a manner consistent with feedback regulation discussed in chapter 2. Already by stage
21, PPT treatment results in significantly decreased expression of ESR1, and increased
expression of PGR and AR in alligator MD compared with controls and E2 treatment.
Interestingly, at stage 21 ESR1 and AR are strongly expressed in control MD at both
MPT and FPT, while ESR2 and PGR and have little to no expression in control MD.
Both PPT and E2 treatments result in increased expression of PGR and AR at stage 21,
though E2 expression activation is to a much lesser degree. This trend continues at later
developmental stages, supporting the hypothesis that the effects of PPT treatment on
alligator MD are due to its selective ERα activation.
PCNA is a DNA polymerase-associated protein used as a marker of cellular
proliferation (Helguero et al., 2005; Krishna et al., 1994). PCNA expression has been
used as a proliferative marker in juvenile alligator oviduct, when it was shown to increase
following treatment with follicle stimulating hormone (FSH) (Moore et al., 2012). There
were no differences in PCNA expression in the experiment detailed in ch.2, despite the
dramatic size increase in PPT-treated MD compared with other treatment groups. As these
tissues were only sampled at stage 27, it was hypothesized that PPT-induced cellular
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proliferation occurred prior to stage 27. However, in this experiment, the only PCNA
expression differences were seen at stage 25, and they weren’t as dramatic as would be
expected. Based on just this marker, the role of active proliferation in the PPT-induced
MD phenotype and the time point at which it occurs remains to be elucidated.
The experiment involving the 2013 sample set, designed to further elucidate the
hypothesis that the PPT-induced phenotype is due primarily to selective ERα activation,
does not provide as much insight as expected. The effects of EB closely matched those
of E2, and the effects of PPT treatment seen in the multi-stage experiment occurred
relatively rapidly following administration, suggesting that the effects of PPT are not
due to this pharmaceutical agonist having a longer half-life than endogenous estrogen.
The lack of attenuation of the PPT treatment-induced effects by co-treatment with WAY
contradicts the proposed hypothesis attributing the PPT-induced MD phenotype to
imbalanced signaling between the ER isoforms. This result may be due to factors related
to the experimental design, however, such as the timing of dose administration and the
doses themselves.
At stage 19, when the treatments were administered, ESR2 transcript levels are
not detectable via QPCR, and levels of ESR2 remain much lower than those of other
SHRs throughout embryonic development, as shown in FPT controls in the staged
experiment. It is therefore possible that ERβ levels in the alligator MD are too low for
their selective activation with WAY to have downstream signaling effects strong enough
to regulate the effects of ERα activation via PPT.
While the pharmaceutical agonists used in this experiment were selected due
to their specificity for ERα and ERβ via receptor transactivation assay in vitro (Kohno
et al., 2015), the doses utilized were based on the receptor kinetics of the agonists on
each single receptor isoform in isolation, rather than the co-existence of both of the ER
isoforms in vivo. Taken alongside the observed differences in receptor isoform expression
levels in the embryonic MD, it is highly likely that the dosage of WAY used here was not
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enough to induce a level of ERβ activation that could counter the highly activating effects
of PPT on ERα.
Even so, the effects of combinatorial treatment on IGF1 expression provide some
support for the concept of a regulatory role of ERβ on ERα-mediated proliferation in
the alligator MD. The attenuated IGF1 levels made no difference in the PPT-induced
hypertrophy, however, but these transcripts were only measured at stage 27. The multistage experiment showed that PPT-induced hypertrophy begins much earlier, and PPTinduced increases in IGF1 levels are more dramatic at earlier developmental stages, while
transcript levels of ESR2 increase over developmental time. An experiment incorporating
a later dosage time, or multiple doses over a developmental time course, might better
elucidate the interplay between ERα and ERβ signaling in proliferative and differentiative
processes in alligator MD.
Taken together, the results of these experiments support the value of the PPTinduced MD phenotype as a tool for investigating the role of estrogen signaling in the
developing alligator FRT, even if the different effects of PPT treatment and E2 treatment
may be due to some unknown aspect of PPT metabolism in the embryonic alligator. The
response of embryonic alligator MD to PPT follows a similar pattern to the response
of the developing avian FRT to estrogens. This response, particularly at a molecular
signaling level, provides insight into the role of estrogen signaling in developing alligator
FRT, but further experiments are needed to elucidate the specific roles of the estrogen
receptor isoforms in proliferation and differentiation in the developing alligator FRT.
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2011 Samples

2013 Samples

Fig. 3.1 Schematic of experimental designs.
Time points of dosing and collection relative to the thermosensitive period (TSP)
indicated at top; treatments and dosage indicated in charts. Top: 2011 experiment,
bottom: 2013 experiment.
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Fig. 3.2. Effects of treatment on embryonic alligator Müllerian duct morphology at four developmental time points.
Representative photographs of embryonic alligator GAM with attached MD. Treatment and incubation temperature indicated
above images, from left to right: 0.5 μL/g EW EtOH at MPT, 0.5 μL/g EW EtOH at FPT, 0.5 μg/g EW E2 at MPT and 5 μg/g
EW PPT at MPT. Stage of collection indicated at left of images, from top to bottom: 21, 23, 25 and 27. Arrows indicate MD.

Fig. 3.3. Effects of treatment on gonadal histology at stage 27.
Representative cross sections of stage 27 alligator GAM complexes.(A) 0.5 μL/g EW EtOH at
FPT. (B) 0.5 μL/g EW EtOH at MPT. (C) 0.5 μg/g EW E2 at MPT. (D) 5 μg/g EW PPT at MPT.
G = gonad, M = metanephros. sc = sex cords. Arrows indicate ovarian lacunae. Dashed line
indicates base of ovarian cortex. Scale bars = 100 μm.
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MPT
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Fig. 3.4. Effects of treatment on Müllerian duct histology over four developmental stages.
Representative cross sections of embryonic alligator MD. Treatment and incubation temperature indicated above
images, from left to right: 0.5 μL/g EW EtOH at MPT, 0.5 μL/g EW EtOH at FPT, 0.5 μg/g EW E2 at MPT and
5 μg/g EW PPT at MPT. Stage of collection indicated at left of images, from top to bottom: 21, 23, 25 and 27.
Scale bars = 100 μm.
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Fig. 3.5. Regionalized histological and histochemical characteristics of stage 27 PPT-treated embryonic Müllerian duct.
Representative cross sections of stage 27 5 μg/g EW PPT-treated MPT MD. (A) Trichrome
stained anterior region of MD. (B) Trichrome-stained, more posterior region of MD. (C) and (D):
similar regions stained with AB/PAS. (E) and (F): magnifications of (C) and (D), respectively.
Scale bars = 100 μm.
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Fig. 3.6. Lateral view of regionalized histological characteristics of stage 27 PPT-treated Müllerian duct.
Representative lateral section of stage 27 5 μg/g EW PPT-treated FPT embryonic GAM and MD, stained with H&E.
A = adrenal gland, M = mesonephros, G = gonad. Dashed line encompasses MD. Anterior – posterior axis indicated.
Scale bar = 100 μm.

Fig. 3.7. Effects of PPT treatment on steroid hormone receptor expression in Müllerian duct at
four developmental stages.
Relative expression of SHRs normalized to calculated normalization factor. Error bars indicate
mean standard error. Genes indicated to left of graphs, from top to bottom: ESR1, ESR2, PGR,
AR. Stage of collection above, from left to right: 21, 23, 25, 27. Bar color indicates treatment:
black = 0.5 µl/g EW EtOH, MPT; white = 0.5 µl/g EW EtOH, FPT; dark gray = 0.5 µg/g EW

E2; light gray = 5 µg/g EW PPT. p-values via one-way ANOVA indicated above graphs.
Sample size indicated below bars. Letters above bars indicate differences among treatment
groups per Tukey’s multiple comparison post hoc test.

60

Fig. 3.8. Effects of PPT treatment on growth factor expression in Müllerian duct at four developmental stages.
Relative expression of target gene normalized to calculated normalization factor. Error bars
indicate mean standard error. Genes indicated to left of graphs, from top to bottom: EGF, IGF1,
PCNA. Stage of collection above, from left to right: 21, 23, 25, 27. Bar color indicates treatment:
black = 0.5 µl/g EW EtOH, MPT; white = 0.5 µl/g EW EtOH, FPT; dark gray = 0.5 µg/g EW
E2; light gray = 5 µg/g EW PPT. p-values via one-way ANOVA indicated above graphs. Sample
size indicated below bars. Letters above bars indicate differences among treatment groups per
Tukey’s multiple comparison post hoc test.
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Fig. 3.9. Effects of combinatorial treatments of PPT and WAY on expression of genes of interest
in stage 27 Müllerian duct
Expression values reported as relative expression normalized to ACTB. Error bars indicate mean
standard error. Treatment indicated below bars. p-values via one-way ANOVA indicated above graphs.
Sample size indicated below bars. Letters above bars indicate differences among treatment groups per
Tukey’s multiple comparison post hoc test.

62

CHAPTER 4:
The influence of background contaminant exposure on embryonic Müllerian duct
response to in ovo stimulation with estrogen and ERα selective agonist PPT
4.1. Introduction
The American alligator has become a recognized wildlife model for studying the
effects of developmental exposure to environmental endocrine disrupting contaminants in
large part due to more than two decades of research on a population living in Lake Apopka, FL, a site of known heavy contamination with the pesticide DDT. The area around
Lake Apopka has been used heavily for water-intensive agriculture known as muck
farming, and DDT was used extensively on these fields until its ban in 1972 (Conrow et
al., 2011). In 1980 there was a major spill of DDT into the lake from a nearby pesticide
manufacturing plant (United States Environmental Protection Agency, 1994). In 1981, a
significant decline in the population of juvenile alligators in Lake Apopka was observed,
along with significantly depressed egg viability rates and hatching success compared with
other Florida lakes (Woodward et al., 1993; Woodward et al., 2011).
Over the years, measurements of DDT and its metabolites, especially p,p’–DDE,
have been higher in alligator eggs and tissues from Lake Apopka compared with other
Florida lakes (Heinz et al., 1991; Rauschenberger et al., 2004; Woodward et al., 2011).
DDE bioaccumulates in adipose tissue and thus levels remain consistent in populations
over long time periods, and can increase in individuals chronically exposed over a long
lifespan (Turusov et al., 2002). These types of adipose-accumulated contaminants can be
transferred directly from mother to offspring when lipids are mobilized to produce nutritive breastmilk or yolk (reviewed in Hamlin and Guillette, 2011). This type of maternal
transfer occurs in Apopka alligators, as DDT, DDE and other contaminants have been
detected in both egg yolk and in maternal tissue (Rauschenberger et al., 2004; Rauschenberger et al., 2007). DDE at levels detected in yolk from Lake Apopka eggs has been
shown to interact with alligator oviductal protein extract in competitive binding assays
with estrogen or progesterone (Vonier et al., 1996).
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Many anomalies have been documented in Apopka alligators compared with
alligators from reference sites with lower measured contaminant levels. For most of these
studies, Lake Woodruff National Wildlife Refuge has served as the reference site, as it has
historically had fewer anthropogenic influences than Lake Apopka, as well as measurably
lower levels of contaminants, and the alligator population has had much greater reproductive success (Milnes and Guillette, 2008). Egg viability rates and hatching success have
remained consistently lower for Apopka than Woodruff (Guillette et al., 2000; Milnes
and Guillette, 2008) and in studies where eggs were hatched out and maintained under
identical laboratory conditions, Apopka alligators had higher post-hatching mortality than
Woodruff alligators (Milnes et al., 2008). There have been several major morphological and physiological differences documented in alligators between these sites. Juvenile
alligators in Lake Apopka had significantly decreased phallus size with lower plasma
testosterone compared to Lake Woodruff (Guillette et al., 1996). Six-month-old alligators hatched from eggs collected at Lake Apopka and raised under controlled laboratory
conditions exhibited disrupted gonadal morphology, most notably, multi-oocytic ovarian
follicles reminiscent of those seen in mice exposed in utero to DES (Guillette et al., 1994;
Guillette and Moore, 2006).
Molecular signals were investigated to probe the potential mechanisms underlying
these ovarian alterations in Apopka alligators. Gonadal ESR2 expression was higher in
field-captured juvenile alligators in Lake Woodruff than in Lake Apopka (Kohno et al.,
2008) and also in 13-month-old alligators collected as eggs from the field sites and reared
under controlled laboratory conditions (Moore et al., 2010b). Laboratory-reared juvenile
alligators collected as eggs from Lake Woodruff exhibited sexually dimorphic expression
patterns of important genes involved in steroidogenesis and members of the transforming
growth factor β (TGF-β) superfamily that promote and regulate ovarian follicle development, while juveniles collected as eggs from Apopka and raised under identical laboratory conditions did not (Milnes et al., 2008; Moore et al., 2011). At hatch, neonates from
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Lake Apopka had lower gonadal expression of these ovarian folliculogenesis-regulating
TGF-β factors than neonates from Lake Woodruff (Moore et al., 2010a). As measured by
expression levels of folliculogenesis-regulating factors and steroidogenic enzyme aromatase, Apopka neonates exhibited a decreased response to challenge with FSH compared with Woodruff neonates (Moore et al., 2010a), a difference which persisted five
months post-hatch (Moore et al., 2012).
These differences in morphology and molecular signaling in gonads of alligators
from Apopka suggested this developmental exposure could also induce alterations in
FRT. There are no reported differences in FRT morphology between Apopka and Woodruff alligators, but there are noticeable differences in eggs collected from these sites. Over
the years we have collected eggs and incubated them in our laboratory, we have anecdotally noted Apopka eggs are smaller in size and weight than Woodruff eggs, and we have
also observed malformed eggs from Apopka (unpublished observations). This suggests
there may be impairments in reproductively mature Apopka FRT structure or function
that impact egg production.
DDT and its metabolites have been famously implicated in major reproductive
tract disorders in birds, particularly the phenomenon of eggshell thinning. In multiple,
primarily carnivorous species, including pelicans, bald eagles, cormorants and herring
gulls, decreased hatching success and significantly thinner eggshells (>15% reduction)
were positively associated with levels of DDE in eggs, and laboratory exposure experiments confirmed eggshell thinning in birds exposed to DDE (Cooke, 1973). The mechanism of DDE-induced eggshell thinning is still under investigation. Originally it was
thought that DDE interfered with prostaglandin synthesis in the shell gland of the avian
oviduct, thus inhibiting calcium transport (Lundholm, 1997). More recent studies have
shown that embryonic exposure to DDE can directly disrupt the development of the avian
FRT, resulting in altered shell gland function and eggshell thinning (Holm et al., 2006;
Kamata et al., 2009). Thus, exposure to DDE during a critical developmental window
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may induce adverse impacts observed in birds, and alligators from Lake Apopka may be
similarly susceptible to disrupted FRT development due to DDE exposure.
We have established that the developing alligator FRT is receptive to estrogenic
stimulation via ERα, and treatment with the ERα agonist PPT induces hypertrophy and
cellular differentiation in the MD. In vitro receptor transactivation assays have shown that
DDT and DDE are human ER agonists, with greater activity on hERα than hERβ (Kojima et al., 2003). DDT and DDE also activate alligator ERα in in vitro receptor transactivation assays, though their effects on ERβ have not been assessed (Rider et al., 2010).
Thus, exposure to DDE and other EDCs in Apopka alligators could lead to disrupted FRT
development via selective stimulation of ERα.
Our previous investigations of the effects of ER isoform selective agonists on
alligator MD provide a unique tool for testing this hypothesis. We have characterized the
MD response to selective ERα activation via in ovo PPT treatment in alligator embryos
from the relatively pristine environment of Lake Woodruff. Here we investigate whether
background exposure to EDCs alters this ERα-mediated MD response by treating alligator embryos collected from Lake Apopka with PPT. We directly compare the morphological, histological and transcriptional effects of in ovo PPT treatment on MD in alligator
embryos from Lake Apopka and Lake Woodruff.

4.2. Materials and methods
4.2.1. Egg collection, incubation and treatment
All experiments in this study involving alligators were carried out under the protocol approved by the Institutional Animal Care and Use Committee at the Medical University of South Carolina, and all fieldwork was conducted under permits from the Florida Fish and Wildlife Conservation Commission and the U.S. Fish and Wildlife Service.
Alligator eggs were collected from Lake Woodruff National Wildlife Refuge (De
Leon Springs, FL, USA) on 6/20/2013 and Lake Apopka (Lake and Orange Counties, FL,
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USA) on 6/21/2013 under Florida Fish and Wildlife Conservation Commission permits.
Eggs were transported to MUSC facilities (Charleston, SC, USA), weighed, candled,
staged and incubated at 30°C as described in the preceding chapters.
At stage 19, eggs were randomly assigned to treatment groups: 0.5 μL/g egg EW
absolute ethanol; 0.5 μg/g EW E2 (Sigma-Aldrich, St. Louis, MO, USA); 0.5 μg/g EW
or 5 μg/g EW PPT (Tocris Bioscience, Bristol, UK), prepared as described in previous
chapters. Doses were based on the previous experiments, in which these doses of PPT
produced significant differences in MD morphology, histology and gene expression as
compared with the vehicle control and E2 treatment. Treatments were administered by
eggshell painting as previously described, and embryos were incubated at FPT for the
duration of the experiment.
Using the methodology shown in chapter 2, embryos were sacrificed at stage 27
and left and right GAM-MD complexes were collected under a dissecting microscope,
the right side preserved in RNAlater® (Life Technologies, Grand Island, NY, USA) and
the left side in 4% PFA. The fixed tissues were incubated overnight on a shaker at 4°C.
The RNAlater® -preserved tissues were then stored at -20°C. The PFA-fixed tissues were
progressively dehydrated in methanol/PBST over a 24-hour period and stored in 100%
methanol at -20°C.

4.2.2. Histology
PFA-fixed tissues were dehydrated through a series of isopropanol and xylene and
paraffin infiltrated using a Leica ASP300 autoprocessor (Wetzlar, Germany), and embedded into paraffin using a Leica EG1150C embedder. Tissues were serially cross-sectioned
or serially lateral-sectioned at 8 µm using a Leica manual rotary microtome, and stained
with hemotoxylin and eosin using a Leica Autostainer XL with a Leica CV5030 coverslipper.
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For each treatment group, five samples were examined in full, 2-3 as serial cross
sections and 2-3 as serial lateral sections. As in previous chapters, the anterior-posterior
axis of the GAM was utilized as a metric for assessing regionalization of the MD. Representative digital photomicrographs were taken of cross-sectioned samples with a ProgRes
Speed XT core 5 camera (Jenoptik, Jena, Germany) of a region near the anterior end of
the GAM, where both the gonad and adrenal gland are present.

4.2.3. RNA isolation, cDNA synthesis and quantitative PCR
The methods for RNA extraction, cDNA synthesis and QPCR are similar to previous chapters, with minor modifications. RNAlater® -preserved MD tissues were manually separated from GAM complexes under a dissecting microscope and stored at -20°C
until RNA extraction. Whole MDs (n=8 per treatment group) were homogenized for
RNA extraction via the SV Total RNA Isolation System with DNase-I treatment (Promega, Fitchburg, WI, USA). RNA concentration was measured using a Nanodrop Spectrophotometer (Thermo Scientific, Wilmington, DE, USA) and quality was assessed via
denaturing agarose gel electrophoresis. RNA was diluted to matching concentrations and
reverse transcribed using the High-Capacity cDNA Reverse Transcription Kit with RNase
Inhibitor (Applied Biosystems, Foster City, CA, USA) per manufacturer’s protocol, using
10 μL diluted RNA in 20 μL total reaction mix, and the cDNA was diluted 1:5 in nuclease-free water.
QPCR was performed using a CFX96 real-time system (Bio-Rad, Hercules, CA,
USA). Reactions were performed in triplicate using 0.01 U/μl AmpliTaq Gold (Applied
Biosystems, Carlsbad, CA, USA) and a SYBR green reaction master mix consisting of
20mM Tris-HCl (pH 7.75), 50mM KCl, 3mM MgCl2, 4% DMSO, 0.5x SYBR Green
I (Thermo Fisher Scientific, Grand Island, NY, USA), 0.5% glycerol, 0.5% Tween 20,
0.2mM deoxynucleotide mix (Thermo Fisher Scientific), 0.2 µM of each primer mix (Eurofins Genomics, Huntsville, AL, USA), and 1/25 volume diluted cDNA.
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The thermal cycler program consisted of an initial denaturation step (95°C, 5 min) followed by 45 cycles of denaturation (95°C, 15 s) and annealing and elongation at an
optimized temperature (45 s – 1 min, depending on primer set). After the final cycle, a
dissociation curve was generated for each reaction to assess the reaction specificity via an
incremental heating step (+0.5°C/5 s).
Primer sequences, product size and optimal annealing temperatures are listed in
Table 1 (pg. 28). Prior to analysis of unknown samples, the specificity of each primer
pair was confirmed by product sequencing. Plasmid DNA standard curves of known copy
number were generated with these sequenced products. Each 96-well plate of unknown
samples included a standard curve, and all samples, including those of the non-template
control and standard curve, were run in triplicate. Mean expression values of mRNA for
each target gene were normalized to that of beta-actin (ACTB).

4.2.4. Statistical analysis
QPCR data were collected and analyzed using CFX Manager version 3.0 software
(Bio-Rad). After determining that expression of ACTB was not significantly affected by
treatment or site (Apopka vs. Woodruff) via two-way analysis of variance (ANOVA),
expression values of all other genes of interest were normalized to ACTB. Data were
log-transformed to achieve homogeneity of variance. Two-way ANOVA was utilized to
calculate the effects of treatment and site on expression of genes of interest. Outlying
values were removed by examination of a residual plot and a distribution plot of the
transformed data. Significance was set at p < 0.05, and a Tukey’s multiple comparison
post-hoc test was used to detect differences among treatment groups.
All statistical analysis was performed using both JMP12 (SAS Institute, Inc.,
Cary, NC, USA) and Graphpad Prism 6 (Graphpad Software, Inc., LaJolla, CA, USA)
software.
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4.3. Results
4.3.1. Morphometric differences between eggs and embryos from Lake Woodruff and
Lake Apopka are not influenced by treatment
In the clutches of eggs utilized in this experiment, fertility rate was not significantly different between the sites, with 96% fertility for Lake Woodruff and 94% for Lake
Apopka. As embryos were sacrificed prior to hatching, hatch rate could not be determined, but there was no significant difference between sites in mortality over the course
of the experiment between dosing at stage 19 and sacrifice at stage 27 (n = 1 for Apopka
and n = 2 for Woodruff). When eggs were initially brought to the laboratory and candled
for viability, they were weighed, and there was no difference in mean egg weights between the sites for the particular clutches utilized in this experiment.
At time of sacrifice, eggs and embryos were weighed, and there was a significant
difference in egg mass between Woodruff and Apopka (Woodruff = 90.3 0.089g, Apopka = 80.9 0.084g, two-tailed p < 0.0001). There was no significant difference in embryo mass, however (Woodruff = 35.5 0.9 g, Apopka = 33.6 0.06 g, two-tailed t test p =
0.089).

4.3.2. PPT treatment induces similar changes in Müllerian duct morphology and histology in embryos from both Lake Woodruff and Lake Apopka
PPT treatment induced the same MD gross morphology in this experiment as
previously described in chapter 2 (as shown in Fig. 2.1). Compared with MD of controls
and E2 treatment, the MD of stage 27 embryos was massively enlarged in embryos treated
with 5 μg/g EW PPT, and somewhat enlarged in embryos treated with 0.5 μg/g EW PPT.
Within treatment groups, there were no appreciable differences between Woodruff and
Apopka embryos at stage 27. PPT-treated MDs were weighed prior to RNA extraction for
the purposes of proper reagent calculation, and MD masses between Woodruff and Apopka samples was not significantly different (Woodruff = 51.38 7.84 g, Apopka = 35.75
4.02 g; two-tailed t-test p = 0.098).
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The histological findings were also consistent with what was described in chapter 2. In the vehicle control samples and the E2-treated samples, the stage 27 MD was a
simple tube with a columnar epithelium surrounding the lumen and a fibroblastic mesenchymal stroma (Fig. 4.1 A-D). Treatment with 0.5 μg/g EW PPT induced enlargement
of the MD that involved stromal hypertrophy, as described in ch. 2, in both Woodruff and
Apopka samples (Fig. 4.1 E, F). At the highest dose, 5 μg/g EW, PPT treatment induced
the phenotype of MD hypertrophy with precocious glandular differentiation detailed in
previous chapters. There were no observable differences between Apopka and Woodruff
embryos at stage 27 in this treatment group (Fig 4.1. G, H).

4.3.3. PPT treatment induces similar changes in expression of genes of interest in Müllerian duct in embryos from both Woodruff and Apopka
As in previous experiments, PPT treatment induced significant changes in expression of SHRs and IGF1 compared with vehicle control and E2 treatment (Fig. 4.2)
Treatment with 5 μg/g EW PPT reduced MD ESR1 about fourfold in both Woodruff and Apopka samples compared with control and E2-treated samples. ESR1 was
somewhat reduced in 0.5 μg/g EW PPT-treated Woodruff MD samples, but not in Apopka samples. ESR2 was increased in 0.5 μg/g EW and 5 μg/g EW PPT-treated samples
compared to controls, in both Woodruff and Apopka MDs. This increase was greater
in samples from Apopka than in Woodruff, with a five-fold increase in ESR2 expression in PPT-treated Apopka MDs compared to controls, and only a two-fold increase in
PPT-treated Woodruff MDs compared to controls.
PPT treatment significantly increased expression of PGR compared to controls
and E2 treatment in both Woodruff and Apopka MDs. While PGR levels were similar in
both 0.5 μg/g EW and 5 μg/g EW PPT-treated Woodruff samples, in Apopka samples, 5
μg/g EW PPT treatment induced significantly higher PGR expression than 0.5 μg/g EW
PPT treatment.
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For both AR and IGF1, expression was significantly higher in PPT-treated MDs
than controls or E2-treated MDs in both Woodruff and Apopka samples, with no significant differences between the sites.

4.4. Discussion
Overall, the MD response to PPT treatment in Apopka embryos was very similar to that of Woodruff embryos. There are no previously documented morphological or
histological differences between MDs or immature oviducts from Apopka and Woodruff
alligators, which is unsurprising in light of our findings documented in previous chapters.
The developing alligator MD only exhibits morphological changes through in ovo treatment with extreme doses of estrogens or progestins (Austin, 1991; Lang and Andrews,
1994) or via selective activation of ERα as our experiments have shown. DDE and other
contaminants present in Apopka egg yolk are unlikely to be as highly endocrine active.
Indeed, DDT and its metabolites were shown to have low affinity for alligator oviductal
protein extract in competitive binding assays with estrogen and progesterone, although
mixtures of contaminants found in Apopka eggs had a greater than additive effect (Vonier
et al., 1996). In vitro receptor transactivation assays also showed DDT and DDE were
weakly activating of alligator ERα (Rider et al., 2010). Experimental treatment of alligator embryos from Lake Woodruff with 100 ppb DDE increased female:male sex ratio at
the intermediate incubation temperature, but did not alter MD morphology or MD epithelial cell height (Milnes et al., 2005).
No major oviductal differences have been reported in adult Apopka alligators,
but differences in egg mass, morphology, viability and hatching success have all been
documented. While eggshell thinning has been highly correlated with DDE exposure in
birds, no studies support DDE-induced eggshell thinning in alligators. In 1985, there was
no significant difference found between shell thickness of eggs from Lake Apopka and a
reference site, and there was even a slight positive correlation between DDE residues in
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eggs and eggshell thickness (Heinz et al., 1991). A multi-year study of eggshells collected
after laboratory hatch-out found Apopka eggs actually had thicker shells than Woodruff
eggs (Bryan, 2005).
While the levels of DDE measured in alligator eggs in Lake Apopka are consistently higher than those measured at other sites, they are lower than levels documented
in bird populations that were significantly impacted by DDE-induced eggshell thinning.
Between 1984 and 2002, DDE levels in Apopka alligator eggs were measured several
times and average levels ranged from 3.5 - 5.8 ppm (Heinz et al., 1991; Rauschenberger
et al., 2007; Woodward et al., 2011). A study of bald eagles suffering a serious DDT-associated population decline in Ontario reported levels of DDE in eggs as high as 94 ppm
prior to the ban of DDT, and by1981 levels had dropped to a mean of 29 ppm and both
hatching rate and eggshell thickness had improved significantly (Grier, 1982). However,
avian FRT anomalies have been documented at lower levels of DDE exposure as well. In
brown pelicans, 4 - 5 ppm DDE in eggs was correlated with 15% eggshell thinning, and
reproductive impairment occurred above 2.5 ppm (Blus et al., 1974).
More recent laboratory studies have directly correlated in ovo exposure to DDT
with changes in reproductive system patterning that lead to eggshell thinning in chickens
(Holm et al., 2006) and Japanese quail (Kamata et al., 2009). This impairment in oviductal function is accompanied by obvious structural changes including foreshortening of the
left oviduct and retention of all or part of the right oviduct, which normally completely
regresses in these birds (Holm et al., 2006; Kamata et al., 2009). These types of oviductal
anomalies are also seen in birds following in ovo exposure to other estrogens and estrogenic contaminants such as DES, ethinyl estradiol, EB and bisphenol A (Berg et al., 1999;
Brunstrom et al., 2009; Halldin, 2005; Rissman et al., 1984).
Taken together, it is appears that alligator MD differs from avian MD in responsiveness to estrogenic stimulation. It takes a large, imbalanced ERα stimulation to induce
observable morphological changes in alligator MD similar to those observed in avian
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studies utilizing much lesser estrogenic stimuli. However, the alligator MD does show
estrogenic treatment-induced alterations on a more subtle molecular level. In a study of
5-month-old laboratory-reared alligators, FSH challenge elicited an increase in transcript
levels of PGR and AR in oviducts from animals collected as eggs from Lake Woodruff
and not in those from Lake Apopka. In this study, we also found subtle differences in
SHR expression between Woodruff and Apopka alligators, with Apopka alligators exhibiting larger PPT treatment-induced increases in ESR2 and PGR.
In previous chapters we have posited that ESR2 and PGR expression is altered by
PPT treatment as a feedback response, as negative regulators of ESR1 signaling. The differences in PPT-induced expression changes of these genes in Apopka embryos compared
with Woodruff embryos suggests there may be alterations in steroid hormone regulatory
responses in Apopka alligators.
In conclusion, developmental exposure to endocrine disrupting contaminants at
ecologically relevant doses, as represented by yolk contaminants in embryos from Lake
Apopka, does not have any observable impacts on the developing alligator MD. However, this background exposure can result in altered molecular signaling responses to additional endocrine stimulus, such as the treatment regime in this experiment. The repercussions of this altered response on FRT function and, by extension, the overall reproductive
health of alligators, is not known and requires further investigation.
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Fig. 4.1. Effects of PPT treatment on histological characteristics of stage 27 Müllerian duct in
alligators from a reference site vs. those from a site of known contamination.
Representative cross sectional photomicrographs of FPT stage 27 alligator GAM and MD from
Lake Woodruff (left) and Lake Apopka (right). Treatments indicated to the left of images, from top
to bottom: 0.5 µL/g EW EtOH, 0.5 µg/g EW E₂, 0.5 µg/g EW PPT and 5 µg/g EW PPT. Stained
with H&E. Scale bars = 100 μm
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Fig. 4.2 Effects of PPT treatment on expression of genes of interest in stage 27 Müllerian duct
from alligators from a reference site vs. those from a site of known contamination.
Expression values reported as relative expression normalized to ACTB. Error bars indicate
mean standard error. Treatment indicated below bars. Black bars = Lake Woodruff samples,
white bars = Lake Apopka samples. p-values via two-way ANOVA indicated above graphs.
Sample size indicated below bars. Letters above bars indicate differences among treatment
groups per Tukey’s multiple comparison post hoc test.
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CHAPTER 5:
General discussion
5.1. Summary
The overarching goal of this dissertation research was to investigate the development of the female reproductive tract of the American alligator in the context of endocrine disruption. The endocrine disruption hypothesis has become an established paradigm guiding investigations that are critical for the health of humans and all other life on
the planet, which makes it by necessity broad and transdisciplinary. The foundations of
this field are “basic science” investigations, however; and when I entered graduate school
and expressed my lofty aims to my mentor, Dr. Louis Guillette, I quickly learned one of
his most often-repeated maxims, “You can’t understand ‘abnormal’ until you understand
‘normal.’”
In the case of alligator FRT development, “normal” was far from established.
Studies on alligator reproductive physiology examined mature FRT and positioned the
alligator FRT as closer, from an evolutionary standpoint, to birds than to other reptiles,
though it displayed characteristics of both (Palmer and Guillette, 1992). There is a dearth
of studies on the developmental differentiation of alligator FRT, ostensibly due to the
difficulty of studying a slow-maturing, long-lived, large predator.
The embryonic alligator MD is a simple, uniform tube. The only documented
regional difference in normal female alligator MD was discussed in ch. 2: the MD region
at the posterior terminus of the adrenal gland of the GAM displays a thickened luminal
epithelium. This characteristic is only present for a very short portion of the MD, and its
significance is unknown, but it was consistently seen in all FPT control MD, suggesting
that it is a normal characteristic of developing alligator FRT (Doheny et al., 2016). The
age at which the alligator FRT normally becomes regionally differentiated under natural
conditions is unknown. Differentiation of the oviduct has not been reported in any laboratory studies involving untreated female alligators reared from hatching until as old as 1.5
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years of age (Forbes, 1938b). In my own experience necropsying female alligators reared
for about 6 months post-hatch in the laboratory, until they had attained one kg body mass,
the oviducts were simple, thin tubes for nearly their entire length, with some sinuous
curving at the anterior end. Histologically, no major differences were seen in serial cross
section or in lateral sectioning of coiled tissues; the oviducts were similar to the embryonic MD, with a central lumen surrounded by a simple columnar epithelium and a fibroblastic stroma.
The age at which alligators are reproductively mature is variable, ranging from
10-18 years, depending on temperature and nutrient availability (Lance, 2003). The more
important determinant of maturity is body size, and the most reliable, standardized morphometric used in studies of alligator populations is the length from the tip of the snout
to the vent (SVL). Alligators attain reproductive maturity at a SVL of 90 cm (Wilkinson
and Rhodes, 1997). From the aforementioned unpublished study we conducted in which
alligators were hatched out and reared in the lab until they reached one kg in mass, the
average SVL at hatch was 12.3 ± 0.4 cm, and the SVL at sacrifice was 33.5 ± 0.9 cm.
There is some evidence to suggest that alligators enter peripubescence above a threshold
size of approximately 38 cm SVL, as wild juvenile alligators begin to show pronounced
seasonal variation in circulating sex hormones (Rooney et al., 2004). Thus, differentiation
of the alligator oviduct normally occurs after it becomes prohibitive to maintain alligators
in the laboratory due to their size, and likely involves hormone signaling during a pubertal phase.
While still pondering the best methods for studying alligator FRT development
given this major limitation, as part of a different study aimed at investigating gonadal sex
determination we unexpectedly induced a hypertrophied MD phenotype heretofore never
seen in our research group. This experimentally-induced phenotype, while not a direct
reflection of “normal” FRT development, nevertheless provided a model for investigating
how the embryonic MD responds to estrogenic stimulation, and the implications of this
response for the process of normal FRT differentiation.
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Over the course of this investigation, I established the basic characteristics of the
MD phenotype induced via treatment with the selective ERα agonist PPT. The massive
MD enlargement easily observed with the naked eye during necropsy was examined at a
histological level, initially to determine whether this enlargement was due to hypertrophy
or hyperplasia. I discovered that while there was hypertrophy of stromal cells, the more
striking characteristic was differentiation of luminal epithelial cells into glandular structures similar to the process of adenogenesis in the mammalian and avian FRTs. Numerous
studies have detailed induction of glandular formation in avian and mammalian FRT by
developmental exposure to endogenous and exogenous estrogens and estrogenic contaminants (reviewed in Dougherty and Sanders, 2005; Kurita, 2011). My discovery of glandulogenesis in embryonic alligator MD is thus not unique if considered in the context of the
FRT development in amniotes, but the intriguing aspect of it is that only treatment with a
pharmacological selective agonist of ERα induced this glandulogenesis. As detailed in the
introduction, previous studies involving treatment with E2, synthetic estrogens, or estrogenic compounds, did not induce this response in alligators (Austin, 1989, 1991; Forbes,
1938b). Both the developing mammalian and avian FRTs seem much more labile to estrogen signaling than the alligator, as major FRT structural changes have been reported in
birds and mammals following embryonic exposure to estrogens (reviewed in Dougherty
and Sanders, 2005; Iguchi, 2000; Kurita, 2011).
The novelty of the PPT-induced phenotype in alligator MD could well be due to
the fact that alligators are simply not that well-studied; if the alligator was a more popular
and accessible model, more rigorous testing of endocrine active compounds during alligator development might have resulted in other incidences of this phenotype. Alternatively,
the factors determining alligator FRT differentiation could be quite different from those
guiding differentiation in more well-studied models with genetic, rather than environmental, sex determination. In mammals, where SRY on the Y chromosome guides male sex
determination, the XX female is considered the “default” state, with ovarian differentia79

tion occurring in the absence of SRY, and FRT differentiation occurs in a similar default
fashion, in the absence of male-determining endocrine factors (Gilbert, 2000; vom Saal et
al., 1992). In birds, the ZW female only receives a “half-dose” of the Z-linked male-determining factor DMRT1, and thus ovarian differentiation also occurs in the absence
of the male signal (Smith et al., 2009). Designating FRT differentiation as a the default
system in birds is a more complicated picture than in mammals, however, as AMH is
produced in both males and females, and ovarian estrogens are necessary for protecting
the FRT against AMH-induced degeneration (Hamilton, 1961). This begs the question:
in alligators and other animals with temperature dependent sex determination, is there a
“default” system? What factors actually drive reproductive tract differentiation?
Interestingly, studies have demonstrated that estrogens administered prior to the
thermosensitive window of sex determination can induce ovarian development in alligators incubated at MPT, indicating that estrogens can override the male-determining
thermal signal, while thus far no androgenic treatment has induced testis development at
FPT (Kohno and Guillette, 2013; Lance and Bogart, 1992). This may indicate that female is the “default” state in alligators, i.e., in the absence of a male-determining signal,
female differentiation occurs. This idea is supported by the fact that there is a much larger
range of temperatures that bias female differentiation in the alligator and a larger window
of time in which these temperatures can bias toward female sex determination (Kohno
and Guillette, 2013; McCoy et al., 2015). Once gonadal differentiation has occurred,
testis-produced AMH leads to MD degeneration, which is completed prior to or not long
after hatch out, whereas in the female, the MD is maintained but remains undifferentiated
until much later. Experimental evidence suggests that estrogen can be protective against
MD regression in alligators, but is not necessary in normal female development. When
female neonates were ovariectomized and given a graft of testicular tissue, the MDs
regressed, but MD regression did not occur in ovariectomized neonates given a graft of
muscular tissue, nor in ovariectomized, testis-grafted females implanted with a slow-re80

lease pellet of E2 (Austin, 1989). Thus, perhaps the best descriptor for the developing
alligator FRT is not “default” but rather “passive,” as it can be responsive to exogenous
estrogen stimulation, particularly via ERα, but does not need estrogenic signals during
embryonic development. The immature FRT remains undifferentiated until it receives the
appropriate signal driving regionalized cytodifferentiation at a much later developmental
time point.

5.2. Future directions
A role for estrogen signaling in this later regionalized differentiation of the alligator FRT is strongly suggested by experiments described in the previous chapters characterizing the regionalized cytodifferentiation of the MD induced by in ovo PPT treatment.
Across all of the experiments described, stage 27 alligator MD treated at stage 19 with 5
μg/g EW PPT had a greater density of glandular structures in the anterior portion of the
MD, decreasing posteriorly. This could be due to the treatment operating on an anterior-posterior gradient, and having a stronger effect on the anterior regions, or it could be
due to underlying factors guiding regional differentiation of the FRT. The adult alligator
FRT is highly regionalized, and the anterior tube similarly displays the greatest density of
glands (Palmer and Guillette, 1992). Many genetic factors have been identified that are
involved in regional differentiation of the mammalian FRT (Kobayashi and Behringer,
2003) and it would be worthwhile to investigate similar factors in alligator FRT differentiation.
In investigations of these regulatory factors involved in FRT differentiation, a target
of particular interest are the Homebox (Hox) genes, due to their ubiquity in axis-determining patterns in embryos. As mentioned in chapter one, regional expression of the
Hoxa 5’ genes correlate with the regional differentiation of the FRT in mammals (Ma
et al., 1998; Taylor, 2000), and experimental evidence suggests that estrogens regulate
regional expression of Hoxa 5’ genes in the developing FRT (Akbas et al., 2004). Devel81

opmental exposure to the synthetic estrogen diethylstilbestrol in mice results in a posterior shift of Hoxa9, Hoxa10 and Hoxa11 gene expression, and reproductive tract abnormalities indicative of a posterior shift of specialized structures (Block et al., 2000; Ma et
al., 1998). Thus, future investigation into the effects of treatment with E2 and estrogen
receptor-selective agonists on Hox gene expression in specific regions of the alligator
MD could be valuable in better understanding regional patterning of FRT differentiation
in alligators and other vertebrates.
Further, a greater understanding of the molecular mechanisms underlying the
development of the alligator oviduct could inform general understanding of the evolution
of viviparity. Hoxa10 has been shown to have an important role in successful implantation and maintenance of pregnancy in mammals, which has led to investigations into its
role in structural adaptations associated with the transition from oviparity to viviparity.
Hoxa10 knockdown in cycling mouse uterus prior to implantation results in decreased
formation of pinopods, projections from nonciliated endometrial epithelium that are associated with implantation success (Bagot et al., 2001). Pinopods have been documented
in viviparous, but not oviparous reptiles, and different isoforms of Hoxa10-like proteins
were found in the adult oviducts of an oviparous lizard (Lampropholis guichenoti) and a
viviparous lizard (Eulamprus tympanum) (Thomson, 2006; Thomson et al., 2005). Under
this hypothesis of uterine Hoxa10 expression being associated with viviparity, considering the evolutionary Archosaurian lineage of alligators and other crocodilians, detecting
Hoxa10 gene expression in the alligator FRT would be an interesting finding.
I proposed to investigate regionalized Hox gene expression in the alligator MD
using in situ hybridization when I was awarded a fellowship through the National Science
Foundation and the Japan Society for the Promotion of Science to work in the laboratory
of Dr. Taisen Iguchi. By utilizing a sample set from my experiments involving treatment
with E2 and PPT, I planned to determine whether Hox genes were expressed in alligator
MD at all, using the control samples, and then whether normal expression patterns were
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altered by estrogenic treatment. Unfortunately, I was not issued the necessary CITES permit to export alligator tissues to Japan in time, and without the expertise of my Japanese
colleagues I was unable to complete this experiment. I believe this remains an intriguing
and potentially highly informative area for further research into the development of the
alligator FRT.

5.3. Conclusions
As an intial foray into a complex developmental process in a non-model species
from a complex environment, this study had its limitations, but still provides some valuable insights into potential regulatory mechanisms involved in alligator FRT differentiation. The discovery that the alligator MD can be influenced to precocious glandulogenesis
by developmental exposure to PPT is significant for its novelty in the alligator, particularly because it demonstrates a bias of signaling through ERα in the differentiation of the
FRT. The experiments described in this dissertation support the hypothesis that stimulation of ERα via a selective agonist, without effective ERβ stimulation to play a regulatory
role, induces proliferation and differentiation in the MD. While these experiments did not
clearly define the role of signaling through ERβ in regulating the proliferative and differentiative effects of ERα signaling on alligator FRT differentiation, they provided supportive evidence that the effects of PPT are most likely due to its selective ERα activation
rather than non-target effects of this compound.
As with any scientific investigation, this dissertation produced more questions
than it answered, particularly by illuminating the gaps in the general understanding of the
normal process of FRT differentiation in alligators, and even all other vertebrates evaluated for comparative purposes. It seems that the convention of considering reproductive
tract differentiation to be “default,” simply an accessory to gonadal differentiation, is
short-sighted. There are important signaling factors known to be involved in regulating
regional patterning of the FRT, and there is strong evidence that these factors are regu83

lated by steroid hormone signaling. The role of endocrine signaling in the developmental
differentiation of the MD to the regionally specialized structures of the mature FRT is
clouded by the role of endocrine signaling in the reproductively mature FRT itself, as it
must be remarkably plastic and hormone-responsive in order to dramatically increase
in size and provide the necessary components for fertilized eggs to develop into healthy
offspring. This means that estrogen signaling can play a different role in the embryonic
development of the FRT than in the later remodeling of the reproductively active FRT,
which makes it difficult to draw conclusions from experiments involving treatment of
developing embryos with exogenous estrogens.
All in all, the female reproductive tract is evolutionarily and developmentally
remarkable: it originates as a very simple tube composed of two cell types, and under the
influence of a proper signaling environment, transforms into a structure of specialized regional functionality that is capable of packaging offspring into a protected, nutrient-filled
environment or directly connecting offspring to the mother’s body for developmental nurturing. In short, a properly functioning FRT is crucial for producing healthy offspring, and
proper functioning of the FRT is reliant on proper developmental patterning. The modern
world has put this process in jeopardy, with the prevalence and ubiquity of EDCs released
into the environment. If we are to protect the future of life on this planet, our only recourse is to seek greater understanding of the fundamental “normal” processes guiding
the development of the FRT, in order to protect these processes against “abnormal.”
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